<?xml version="1.0" encoding="UTF-8"?>
<svg height="709.522" width="550.247" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <g begin="text">
   <text y="39.85" x="526.271,530.375,534.479" svgx:width="0.51,0.51,0.51" style="fill:rgb(0,0,0);font-family:MyriadPro-Regular;font-size:8.0px;stroke:none;">325</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M56.690 50.750 L538.690 50.750 "/>
  <g begin="text">
   <text y="95.041" x="56.693,59.888,65.033,67.865,73.147,77.596,80.429,85.711,90.219,93.414,97.863,101.695,109.927,112.553,118.012,122.598,127.88,130.712,135.867,141.189,144.442,147.274,152.674,157.133,162.592,167.874,170.706,177.743,182.319,186.073,191.472,194.099,199.557,204.261,207.094,214.13,216.756,219.95,225.35,228.182,232.043,237.247,241.618,246.89,249.723,254.182,259.64,264.922,267.755,274.791,279.162,282.357,286.806,290.559" svgx:width="0.33,0.52,0.23,0.53,0.45,0.23,0.54,0.45,0.33,0.45,0.38,0.84,0.27,0.56,0.45,0.54,0.23,0.53,0.54,0.33,0.23,0.55,0.46,0.56,0.54,0.23,0.71,0.46,0.39,0.55,0.27,0.56,0.48,0.23,0.71,0.27,0.33,0.55,0.23,0.39,0.52,0.46,0.54,0.23,0.46,0.56,0.54,0.23,0.71,0.46,0.33,0.45,0.38,0.23" style="fill:rgb(0,0,0);font-family:WarnockPro-Regular;font-size:9.8px;stroke:none;">to be determined but hand washing with soap and water </text>
   <text y="107.036" x="56.693,61.838,65.591,67.845,69.07,74.47,78.929,84.388,89.67,91.924,93.149,97.02,102.341,107.496,112.651,115.277,120.736,125.44,127.694,128.919,135.955,138.582,141.777,147.176,149.42999999999998,150.655,156.271,162.18,169.383,171.637,172.862,175.743,180.888,184.642,186.896,188.121,190.679,195.824,201.282,205.986,210.435,214.189,216.44299999999998,217.668,220.863,226.262,230.721,236.18,238.434,239.659,244.579,249.498,251.75199999999998,252.98,256.782,259.036,260.261,268.493,272.825,277.313,279.567,280.792,286.074,290.523" svgx:width="0.52,0.38,0.23,0.55,0.55,0.46,0.56,0.54,0.23,0.55,0.38,0.54,0.53,0.53,0.27,0.56,0.48,0.23,0.55,0.71,0.27,0.33,0.55,0.23,0.55,0.56,0.6,0.74,0.23,0.55,0.3,0.52,0.38,0.23,0.55,0.26,0.52,0.56,0.48,0.45,0.38,0.23,0.55,0.33,0.55,0.46,0.56,0.23,0.55,0.5,0.5,0.23,0.55,0.39,0.23,0.55,0.84,0.46,0.46,0.23,0.55,0.53,0.45,0.23" style="fill:rgb(0,0,0);font-family:WarnockPro-Regular;font-size:9.8px;stroke:none;">or hand rubbing with EBD for longer than 30  s may be </text>
   <text y="119.031" x="56.693,63.729,68.188,72.02,75.774,80.233,85.603,88.798,93.384,98.666" svgx:width="0.71,0.46,0.38,0.38,0.46,0.56,0.33,0.45,0.54,0.23" style="fill:rgb(0,0,0);font-family:WarnockPro-Regular;font-size:9.8px;stroke:none;">warranted.</text>
   <text y="143.041" x="56.693,61.833,67.838,71.618,77.622,81.454,86.893,88.973,95.112,97.934,101.766,107.204,112.014,115.794,118.617,124.56,130.595,135.066,137.146,140.555,146.499,150.413,152.493,156.325,161.763,166.233,171.672,177.11,180.942,185.587" svgx:width="0.53,0.58,0.37,0.58,0.38,0.53,0.2,0.6,0.27,0.38,0.53,0.45,0.37,0.27,0.58,0.59,0.43,0.2,0.34,0.58,0.38,0.2,0.38,0.53,0.43,0.53,0.53,0.38,0.45,0.59" style="fill:rgb(0,0,0);font-family:MyriadPro-Bold;font-size:10.3px;stroke:none;">Future directions for research</text>
   <text y="155.041" x="56.693,67.64,72.089,74.343,78.371,85.652,88.21,93.355,98.568,103.027,105.585,107.839,111.867,115.16,120.618,126.028,131.349,135.799,141.257,145.775,150.234,152.488,156.516,162.082,165.776,170.97,175.782,179.535,183.994,192.226,200.458,204.907,207.161,211.189,216.589,221.164,224.967,227.221,231.249,236.521,241.842,246.997,249.555,252.229,255.983,261.383,265.969,271.251,273.505,277.533,280.728,286.128,290.577" svgx:width="1.12,0.45,0.23,0.55,0.74,0.26,0.52,0.53,0.46,0.26,0.23,0.55,0.34,0.56,0.55,0.54,0.45,0.56,0.45,0.46,0.23,0.55,0.57,0.38,0.52,0.48,0.38,0.46,0.84,0.84,0.45,0.23,0.55,0.55,0.46,0.39,0.23,0.55,0.54,0.54,0.53,0.26,0.27,0.39,0.55,0.45,0.54,0.23,0.55,0.33,0.55,0.45,0.23" style="fill:rgb(0,0,0);font-family:WarnockPro-Regular;font-size:9.8px;stroke:none;">The Global Influenz a Programm e ha s publishe d the </text>
   <text y="167.036" x="56.693,62.014,67.414,72.745,77.116,80.31,84.896,90.179,92.825,102.899,110.514,118.207,120.853,126.419,131.74,136.895,139.453,142.079,146.519,149.165,156.662,161.199,165.658,168.216,171.411,176.811,179.457,185.533,190.05,193.912,198.449,202.908,206.603,210.993,216.393,219.039,225.997,230.701,235.15,240.609,245.94,250.399,253.045,255.926,261.071,264.824,267.47,270.763,276.222,281.631" svgx:width="0.54,0.54,0.54,0.46,0.33,0.45,0.54,0.23,1.02,0.77,0.79,0.23,0.57,0.54,0.53,0.26,0.27,0.45,0.23,0.77,0.45,0.46,0.26,0.33,0.55,0.23,0.62,0.45,0.39,0.45,0.46,0.38,0.45,0.55,0.23,0.71,0.48,0.45,0.56,0.54,0.46,0.23,0.3,0.52,0.38,0.23,0.34,0.56,0.55,0.54" style="fill:rgb(0,0,0);font-family:WarnockPro-Regular;font-size:9.8px;stroke:none;">updated WHO Public Health Research Agenda for Influ</text>
   <text y="167.041" x="286.955" svgx:width="0.37" style="fill:rgb(0,0,0);font-family:WarnockPro-Regular;font-size:9.8px;stroke:none;">-</text>
   <text y="179.041" x="56.693,61.142,66.601,71.118,75.803,78.037,80.29100000000001,83.378,86.005,91.463,93.717,96.804,103.743,109.143,111.769,116.159,121.559,123.813,126.9,130.596,135.113,138.974,143.511,147.97,151.665,156.055,161.455,163.709,166.796,172.068,175.9,178.527,183.672,187.502,190.129,193.382,196.009,200.527,204.329,206.583,209.67,216.608,221.058,224.752,229.201,231.45499999999998,234.542,237.169,242.451,246.9,252.271,255.524,258.151,263.55,268.137,273.419,275.673,278.76,281.641,286.786,290.54" svgx:width="0.45,0.56,0.45,0.46,0.23,0.23,0.55,0.27,0.56,0.23,0.55,0.71,0.55,0.27,0.45,0.55,0.23,0.55,0.38,0.45,0.39,0.45,0.46,0.38,0.45,0.55,0.23,0.55,0.54,0.38,0.27,0.52,0.38,0.27,0.33,0.27,0.45,0.39,0.23,0.55,0.71,0.45,0.38,0.45,0.23,0.55,0.27,0.54,0.45,0.56,0.33,0.27,0.55,0.45,0.54,0.23,0.55,0.3,0.52,0.38,0.23" style="fill:rgb(0,0,0);font-family:WarnockPro-Regular;font-size:9.8px;stroke:none;">enza, in which research priorities were identified for </text>
   <text y="191.036" x="56.693,60.554,65.19,69.747,74.196,77.949,82.408,84.966,87.22,91.36,96.643,101.788,110.02,114.479,117.105,122.564,126.366,128.62,132.76,135.386,140.845,145.235,147.793,153.114,158.396,161.023,166.481,171.185,173.439,177.58,182.911,187.281,190.534,193.161,197.61,202.98,206.234,208.488,212.629,220.861,225.32,230.778,235.237,239.941,244.39,252.622,257.072,262.442,265.696,267.95000000000005,272.09" svgx:width="0.39,0.45,0.47,0.45,0.38,0.46,0.26,0.23,0.55,0.54,0.52,0.84,0.46,0.27,0.56,0.39,0.23,0.55,0.27,0.56,0.45,0.26,0.54,0.54,0.27,0.56,0.48,0.23,0.55,0.54,0.46,0.33,0.27,0.45,0.56,0.33,0.23,0.55,0.84,0.46,0.56,0.46,0.48,0.45,0.84,0.45,0.56,0.33,0.23,0.55,0.33" style="fill:rgb(0,0,0);font-family:WarnockPro-Regular;font-size:9.8px;stroke:none;">several domains including patient management [</text>
   <text y="191.036" x="275.285,280.204" svgx:width="0.5,0.5" style="fill:rgb(0,0,255);font-family:WarnockPro-Regular;font-size:9.8px;stroke:none;">76</text>
   <text y="191.036" x="285.124,288.319,290.553" svgx:width="0.33,0.23,0.23" style="fill:rgb(0,0,0);font-family:WarnockPro-Regular;font-size:9.8px;stroke:none;">]. </text>
   <text y="203.031" x="56.693,62.328,67.13,69.805,73.608,76.861,79.488,84.946,89.65,91.90400000000001,93.08,98.039,103.498,108.643,115.581,118.139,122.725,128.008,132.712,137.161,139.415,140.591,145.991,148.617,153.369,158.769,161.327,163.953,168.706,174.018,177.389,181.191,183.445,184.621,187.816,193.216,197.665,199.91899999999998,201.095,206.553,211.14,215.726,221.009,223.26299999999998,224.439,227.32,232.465,236.218,238.47199999999998,239.648,244.979,249.35,252.663,257.122,259.37600000000003,260.552,264.246,268.754,273.517,277.976,281.671" svgx:width="0.56,0.49,0.27,0.39,0.33,0.27,0.56,0.48,0.23,0.55,0.5,0.56,0.52,0.71,0.26,0.45,0.54,0.48,0.45,0.23,0.55,0.55,0.27,0.48,0.55,0.26,0.27,0.48,0.55,0.33,0.39,0.23,0.55,0.33,0.55,0.45,0.23,0.55,0.56,0.45,0.45,0.54,0.23,0.55,0.3,0.52,0.38,0.23,0.55,0.54,0.46,0.33,0.46,0.23,0.55,0.38,0.45,0.48,0.46,0.38,0.54" style="fill:rgb(0,0,0);font-family:WarnockPro-Regular;font-size:9.8px;stroke:none;">Existing knowledge highlights the need for data regard</text>
   <text y="203.041" x="286.955" svgx:width="0.37" style="fill:rgb(0,0,0);font-family:WarnockPro-Regular;font-size:9.8px;stroke:none;">-</text>
   <text y="215.041" x="56.693,59.319,64.778,69.482,71.736,73.108,76.91,82.232,87.504,92.904,98.049,101.919,105.173,107.799,112.356,116.805,119.05900000000001,120.431,124.949,129.408,133.103,137.552,139.80599999999998,141.178,145.637,151.095,156.378,158.63199999999998,160.004,164.463,169.745,172.224,177.546,183.004,187.502,190.756,193.382,197.939,202.389,204.643,206.015,211.287,216.687,221.146,224.978,233.21,237.669,242.03,247.175,249.732,254.926,259.737,262.364,266.803,269.057,270.429,273.624,279.024,283.473,286.955" svgx:width="0.27,0.56,0.48,0.23,0.55,0.39,0.54,0.54,0.54,0.52,0.38,0.33,0.27,0.47,0.45,0.23,0.55,0.45,0.46,0.38,0.45,0.23,0.55,0.46,0.56,0.54,0.23,0.55,0.46,0.54,0.25,0.54,0.56,0.45,0.33,0.27,0.47,0.45,0.23,0.55,0.54,0.55,0.46,0.38,0.84,0.46,0.45,0.52,0.26,0.52,0.48,0.27,0.45,0.23,0.55,0.33,0.55,0.45,0.38,0.37" style="fill:rgb(0,0,0);font-family:WarnockPro-Regular;font-size:9.8px;stroke:none;">ing supportive care and adjunctive pharmacologic ther-</text>
   <text y="227.041" x="56.693,61.064,66.336,70.825,73.07900000000001,74.7,77.895,83.295,87.666,90.919,93.173,94.795,97.471,101.273,103.527,105.149,108.951,114.35,118.937,123.425,126.051,131.451,135.891,138.14499999999998,139.767,142.648,147.793,151.546,153.79999999999998,155.422,159.91,163.741,166.368,169.621,172.248,176.766,181.225,183.782,186.34,190.829,193.083,194.704,197.331,199.889,202.446,204.7,206.322,211.654,216.024,219.278,221.904,226.354,231.724,235.095,238.898,241.152,242.773,249.81,252.436,255.631,261.031,263.285,264.907,268.767,273.402,277.959,282.409,286.103,290.552" svgx:width="0.46,0.54,0.46,0.23,0.55,0.33,0.55,0.46,0.33,0.23,0.55,0.27,0.39,0.23,0.55,0.39,0.54,0.45,0.45,0.27,0.55,0.45,0.23,0.55,0.3,0.52,0.38,0.23,0.55,0.45,0.38,0.27,0.33,0.27,0.45,0.46,0.26,0.26,0.46,0.23,0.55,0.27,0.26,0.26,0.23,0.55,0.54,0.46,0.33,0.27,0.45,0.56,0.33,0.39,0.23,0.55,0.71,0.27,0.33,0.55,0.23,0.55,0.39,0.45,0.47,0.45,0.38,0.45,0.23" style="fill:rgb(0,0,0);font-family:WarnockPro-Regular;font-size:9.8px;stroke:none;">apy that is specific for critically ill patients with severe </text>
   <text y="239.036" x="56.693,62.612,69.492,72.785,75.019,77.27300000000001,82.026,89.288,93.658,96.97,101.429,103.683,108.436,113.581,119.04,121.29400000000001,126.047,129.849,135.17,140.443,145.842,150.988,154.859,158.112,160.739,165.296,169.745,171.999,176.752,184.984,189.443,194.901,199.36,204.064,208.514,216.746,221.195,226.565,229.819,232.07299999999998,236.826,239.452,244.911,247.165,251.918,255.612,260.13,263.99,269.135,274.457,278.152,282.512,286.962" svgx:width="0.62,0.69,0.34,0.23,0.23,0.55,0.74,0.46,0.33,0.46,0.23,0.55,0.52,0.56,0.23,0.55,0.39,0.54,0.54,0.54,0.52,0.38,0.33,0.27,0.47,0.45,0.23,0.55,0.84,0.46,0.56,0.46,0.48,0.45,0.84,0.45,0.56,0.33,0.23,0.55,0.27,0.56,0.23,0.55,0.38,0.45,0.39,0.52,0.54,0.38,0.45,0.45,0.37" style="fill:rgb(0,0,0);font-family:WarnockPro-Regular;font-size:9.8px;stroke:none;">RVI. Data on supportive management in resource-</text>
   <text y="251.031" x="56.693,60.388,64.905,68.708,71.961,75.793,78.42,82.918,86.113,90.699,95.981,98.235,99.95,103.811,108.319,111.504,114.758,117.384,122.843,127.635,131.438,133.69199999999998,135.407,139.866,143.56,148.009,150.26299999999998,151.978,155.84,160.475,165.032,169.481,173.175,177.556,180.114,184.603,186.857,188.572,191.178,195.637,200.028,204.987,207.613,213.072,218.05,220.284,222.53799999999998,224.253,235.2,239.649,243.344,247.793,250.047,251.762,254.437,258.24,260.494,262.209,266.668,268.922,270.637,276.095,280.682,285.268,290.55" svgx:width="0.38,0.45,0.39,0.33,0.38,0.27,0.45,0.33,0.45,0.54,0.23,0.55,0.39,0.45,0.33,0.33,0.27,0.56,0.48,0.39,0.23,0.55,0.46,0.38,0.45,0.23,0.55,0.39,0.45,0.47,0.45,0.38,0.45,0.26,0.46,0.23,0.55,0.26,0.46,0.45,0.5,0.27,0.56,0.48,0.23,0.23,0.55,1.12,0.45,0.38,0.45,0.23,0.55,0.27,0.39,0.23,0.55,0.46,0.23,0.55,0.56,0.45,0.45,0.54,0.23" style="fill:rgb(0,0,0);font-family:WarnockPro-Regular;font-size:9.8px;stroke:none;">restricted settings are severely lacking. There is a need </text>
   <text y="263.026" x="56.693,59.574,64.719,68.473,70.727,71.496,79.728,84.873,88.567,93.017,95.271,96.045,101.317,105.071,109.53,114.341,122.573,126.943,130.197,132.823,137.263,139.517,140.291,144.75,150.208,155.491,157.745,158.519,162.968,171.112,175.6,178.227,182.676,188.046,191.3,193.554,194.328,199.61,204.128,207.93,210.557,215.368,220.826,224.629,226.88299999999998,227.657,230.852,235.997,238.251,239.02,242.215,246.733,250.535,253.789,256.043,256.812,261.271,266.641,269.895,272.521,277.176,279.803,283.556,288.015,290.573" svgx:width="0.3,0.52,0.38,0.23,0.55,0.84,0.52,0.38,0.45,0.23,0.55,0.54,0.38,0.46,0.48,0.84,0.46,0.33,0.27,0.45,0.23,0.55,0.46,0.56,0.54,0.23,0.55,0.45,0.83,0.45,0.27,0.45,0.56,0.33,0.23,0.55,0.54,0.45,0.39,0.27,0.48,0.56,0.39,0.23,0.55,0.33,0.52,0.23,0.55,0.33,0.45,0.39,0.33,0.23,0.55,0.46,0.56,0.33,0.27,0.47,0.27,0.38,0.46,0.26,0.23" style="fill:rgb(0,0,0);font-family:WarnockPro-Regular;font-size:9.8px;stroke:none;">for more pragmatic and efficien t design s t o tes t antiviral </text>
   <text y="275.021" x="56.693,59.888,65.288,69.737,73.49,77.861,83.261,87.768,93.089,96.343,98.969,103.497,107.534,109.769,112.605,115.231,120.69,125.972,128.598,133.253,135.879,141.161,146.531,150.99,153.548,156.106,160.594,163.431,167.89,173.348,178.63,181.467,184.093,189.552,192.388,196.749,201.894,210.126,215.28,217.907,223.365,227.736,230.99,233.616,238.761,244.22,247.057,249.683,255.142,257.978,263.309,267.68,270.934,273.56,278.009,283.38,286.75,290.552" svgx:width="0.33,0.55,0.45,0.38,0.46,0.54,0.45,0.54,0.33,0.27,0.45,0.39,0.23,0.23,0.27,0.56,0.54,0.27,0.47,0.27,0.54,0.54,0.46,0.26,0.26,0.46,0.23,0.46,0.56,0.54,0.23,0.27,0.56,0.23,0.45,0.52,0.84,0.53,0.27,0.56,0.46,0.33,0.27,0.52,0.56,0.23,0.27,0.56,0.23,0.54,0.46,0.33,0.27,0.45,0.56,0.33,0.39,0.23" style="fill:rgb(0,0,0);font-family:WarnockPro-Regular;font-size:9.8px;stroke:none;">therapeutics, individually and in combination in patients </text>
   <text y="287.017" x="56.693,63.729,66.356,69.551,74.95,77.20400000000001,78.224,82.084,86.719,91.276,95.725,99.42,103.869,106.123,107.142,113.062,119.941,123.234,125.488,126.507,133.446,138.845,143.99,146.244,147.264,151.723,155.417,159.866,162.12,163.14,167.51,170.764,173.018,174.037,176.664,182.122,186.611,190.305,194.843,199.418,203.279,207.866,213.148,215.402,216.421,220.253,222.928,226.682,231.582,233.83599999999998,234.855,237.736,242.881,246.635,248.88899999999998,249.908,254.269,259.414,267.558,272.83,275.388,278.014,282.532" svgx:width="0.71,0.27,0.33,0.55,0.23,0.55,0.39,0.45,0.47,0.45,0.38,0.45,0.23,0.55,0.62,0.69,0.34,0.23,0.55,0.71,0.55,0.52,0.23,0.55,0.46,0.38,0.45,0.23,0.55,0.46,0.33,0.23,0.55,0.27,0.56,0.45,0.38,0.45,0.46,0.39,0.45,0.54,0.23,0.55,0.38,0.27,0.39,0.5,0.23,0.55,0.3,0.52,0.38,0.23,0.55,0.45,0.52,0.84,0.54,0.26,0.27,0.45,0.46" style="fill:rgb(0,0,0);font-family:WarnockPro-Regular;font-size:9.8px;stroke:none;">with severe RVI who are at increased risk for complica</text>
   <text y="287.041" x="286.955" svgx:width="0.37" style="fill:rgb(0,0,0);font-family:WarnockPro-Regular;font-size:9.8px;stroke:none;">-</text>
   <text y="299.041" x="56.693,59.947,62.573,67.718,73.177,76.979,79.233,81.761,84.79,88.484,93.629,101.861,104.11500000000001,106.644,111.926,117.071,120.266,125.665,127.91900000000001,130.448,133.643,139.042,143.492,145.74599999999998,148.274,153.556,156.232,160.093,164.63,169.206,173.067,177.516,179.76999999999998,182.299,186.758,192.216,197.498,199.75199999999998,202.281,205.534,209.228,213.765,218.136,221.39,229.622,234.071,239.441,242.813,246.85,249.085,251.339,253.867,260.717,266.048,270.419,275.692,278.945,281.572,286.129,290.578" svgx:width="0.33,0.27,0.52,0.56,0.39,0.23,0.55,0.3,0.38,0.52,0.84,0.23,0.55,0.53,0.52,0.33,0.55,0.23,0.55,0.33,0.55,0.45,0.23,0.55,0.54,0.27,0.39,0.45,0.46,0.39,0.45,0.23,0.55,0.46,0.56,0.54,0.23,0.55,0.33,0.38,0.45,0.46,0.33,0.84,0.45,0.56,0.33,0.39,0.23,0.23,0.55,0.71,0.54,0.46,0.54,0.33,0.27,0.47,0.45,0.23" style="fill:rgb(0,0,0);font-family:WarnockPro-Regular;font-size:9.8px;stroke:none;">tions from both the disease and treatments. Adaptive </text>
   <text y="311.036" x="56.693,60.446,64.905,70.364,75.646,80.791,89.023,91.747,96.127,100.714,105.996,109.592,113.953,119.098,124.469,127.722,131.417,136.562,139.12,141.678,146.264,151.546,153.996,157.25,161.082,163.757,168.216,170.774,173.224,176.419,181.818,186.189,189.443,191.893,195.088,199.605,203.408,206.779,210.581,213.031,216.893,221.528,226.085,230.534,234.288,238.747,241.304,243.754,247.008,250.703,255.24,259.611,262.864,271.096,275.546,280.916,284.287,288.325,290.559" svgx:width="0.38,0.46,0.56,0.54,0.52,0.84,0.27,0.45,0.45,0.54,0.37,0.45,0.52,0.56,0.33,0.38,0.52,0.26,0.26,0.45,0.54,0.23,0.33,0.38,0.27,0.46,0.26,0.23,0.33,0.55,0.46,0.33,0.23,0.33,0.45,0.39,0.33,0.39,0.23,0.39,0.45,0.47,0.45,0.38,0.46,0.26,0.23,0.33,0.38,0.45,0.46,0.33,0.84,0.45,0.56,0.33,0.39,0.23,0.23" style="fill:rgb(0,0,0);font-family:WarnockPro-Regular;font-size:9.8px;stroke:none;">randomized-controlled trial that tests several treatments, </text>
   <text y="323.031" x="56.693,60.495,65.817,70.207,75.607,77.979,82.555,86.357,88.729,91.924,97.324,101.773,104.145,110.309,116.081,125.499,132.506,137.906,141.502,148.46,155.467,161.034,163.405,166.659,170.491,173.166,177.625,180.183,182.554,185.749,193.423,200.361,206.927,211.847,216.766,221.686,226.605,231.525,236.445,241.364,246.284,249.479,251.713,254.085,262.317,266.648,271.137,273.508,277.203,281.711" svgx:width="0.39,0.54,0.45,0.55,0.23,0.46,0.39,0.23,0.33,0.55,0.45,0.23,0.62,0.56,0.93,0.71,0.57,0.37,0.69,0.71,0.57,0.23,0.33,0.38,0.27,0.46,0.26,0.23,0.33,0.77,0.69,0.67,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.33,0.23,0.23,0.84,0.46,0.46,0.23,0.38,0.45,0.54" style="fill:rgb(0,0,0);font-family:WarnockPro-Regular;font-size:9.8px;stroke:none;">such as the REMAP-CAP trial (NCT02735707), may rep</text>
   <text y="323.041" x="286.955" svgx:width="0.37" style="fill:rgb(0,0,0);font-family:WarnockPro-Regular;font-size:9.8px;stroke:none;">-</text>
   <text y="335.041" x="56.693,60.388,64.905,68.767,73.216,78.586,81.84,84.143,88.602,94.06,96.363,100.813,108.956,113.445,116.071,120.52,125.891,129.144,131.447,135.818,141.091,146.363,150.058,155.261,159.72,164.111,169.511" svgx:width="0.38,0.45,0.39,0.45,0.56,0.33,0.23,0.46,0.56,0.23,0.45,0.83,0.45,0.27,0.45,0.56,0.33,0.23,0.46,0.54,0.54,0.38,0.52,0.46,0.45,0.55,0.23" style="fill:rgb(0,0,0);font-family:WarnockPro-Regular;font-size:9.8px;stroke:none;">resent an efficient approach.</text>
   <text y="353.041" x="56.693,60.555,62.483,66.353,69.833,72.465,75.068,79.298,83.588,85.508,88.875,90.428,93.555,97.823,102.21,106.598,108.525,112.395,118.755,122.625,126.877,129.51,133.32,136.155,139.905,141.457,147.817,151.582,154.17,158.04,160.71,162.63,166.44" svgx:width="0.51,0.26,0.52,0.45,0.35,0.36,0.56,0.57,0.26,0.45,0.21,0.42,0.57,0.58,0.58,0.26,0.52,0.85,0.52,0.57,0.35,0.51,0.36,0.5,0.21,0.85,0.51,0.35,0.52,0.36,0.26,0.51,0.26" style="fill:rgb(0,0,0);font-family:MyriadPro-Semibold;font-size:7.5px;stroke:none;">Electronic supplementary material</text>
   <text y="362.041" x="56.693,60.15,64.17,67.808,69.45,73.44,77.46,79.05,80.618,84.638,88.275,89.918,93.255,96.892,99.105,101.902,103.47,107.46,111.48,113.122,117.112,119.077,120.72,123.037,127.057,128.625,131.422,133.065,136.47,138.877,141.195,142.762,146.107,147.697,151.335,152.977" svgx:width="0.47,0.54,0.49,0.22,0.53,0.54,0.21,0.21,0.54,0.49,0.22,0.45,0.49,0.29,0.37,0.21,0.53,0.54,0.22,0.53,0.26,0.22,0.31,0.54,0.21,0.37,0.22,0.45,0.29,0.31,0.21,0.45,0.21,0.49,0.22,0.26" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">The online version of this article (</text>
   <text y="362.041" x="154.965,158.985,161.302,163.62,167.76,170.557,170.557,171.862,174.495,177.127,181.207,185.197,186.765,188.07,192.06,194.205,198.285,200.917,204.577,208.237,209.542,213.202,216.862,220.522,224.182,226.815,229.612,233.272,236.932,240.592,244.252,244.252,247.912,250.147,253.807,257.467,261.127,263.362,267.022,270.682,274.342,278.002,281.662,281.662,283.897" svgx:width="0.54,0.31,0.31,0.55,0.37,0.22,0.17,0.35,0.35,0.54,0.53,0.21,0.17,0.53,0.29,0.54,0.35,0.49,0.49,0.17,0.49,0.49,0.49,0.49,0.35,0.37,0.49,0.49,0.49,0.49,0.22,0.49,0.3,0.49,0.49,0.49,0.3,0.49,0.49,0.49,0.49,0.49,0.22,0.3,0.49" style="fill:rgb(0,0,255);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">https ://doi.org/10.1007/s0013 4-020-05943 -5</text>
   <text y="362.041" x="287.557,289.545" svgx:width="0.26,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">) </text>
   <text y="371.041" x="56.693,60.038,64.028,68.048,70.365,73.77,75.338,79.358,82.155,83.798,86.595,90.578,94.718,98.858,100.448,104.085,110.228,113.865,117.885,120.203,123.608,126.045,129.345,130.988,137.13,140.535,142.808,146.445,148.71,150.277,153.682,155.19,156.495,158.137,163.552,167.572,169.14,172.485,176.505,178.147,179.715,182.512,184.155,187.515,190.905,194.31,195.877,197.467,200.872,205.012,206.602,210.24,211.882,214.155,218.145,219.787,223.192,227.175,229.492,233.512,237.502,239.767,241.335,244.297,247.935,252.015,253.657,257.64,260.437,264.075,266.287,269.002" svgx:width="0.45,0.53,0.54,0.31,0.45,0.21,0.54,0.37,0.22,0.37,0.53,0.55,0.55,0.21,0.49,0.82,0.49,0.54,0.31,0.45,0.29,0.44,0.22,0.82,0.45,0.31,0.49,0.29,0.21,0.45,0.21,0.17,0.22,0.72,0.54,0.21,0.45,0.54,0.22,0.21,0.37,0.22,0.45,0.45,0.45,0.21,0.21,0.45,0.55,0.21,0.49,0.22,0.31,0.53,0.22,0.45,0.53,0.31,0.54,0.53,0.29,0.21,0.4,0.49,0.54,0.22,0.53,0.37,0.49,0.29,0.37,0.17" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">contains supplementary material, which is available to authorized users.</text>
   <text y="398.041" x="56.693,61.358,65.625,68.258,72.548,76.778,79.448,81.0,85.358,89.228,91.86,95.67,97.59,99.518" svgx:width="0.64,0.57,0.35,0.57,0.56,0.36,0.21,0.58,0.52,0.35,0.51,0.26,0.26,0.42" style="fill:rgb(0,0,0);font-family:MyriadPro-Semibold;font-size:7.5px;stroke:none;">Author details</text>
   <text y="404.041" x="56.693" svgx:width="0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:5.25px;stroke:none;">1</text>
   <text y="407.041" x="59.255,60.897,65.127,69.117,70.707,72.297,75.935,80.015,83.652,85.295,89.285,91.25,92.892,98.787,102.425,106.505,108.072,111.417,112.985,117.005,120.567,121.872,123.515,127.362,128.929,132.949,137.029,138.672,142.152,145.557,149.539,153.619,155.262,159.049,160.617,164.637,166.279,170.667,174.807,178.887,182.869,184.459,187.864,190.887,192.454,195.477,197.119,201.814,205.834,207.402,210.74,214.377,216.59,219.387,220.955,223.355,226.655,228.297,230.15,234.14,236.352,237.995,242.72,246.357,249.762,251.352,253.67,257.69,259.332,262.85,266.195,267.762" svgx:width="0.22,0.57,0.53,0.21,0.21,0.49,0.54,0.49,0.22,0.53,0.26,0.22,0.78,0.49,0.54,0.21,0.45,0.21,0.54,0.49,0.17,0.22,0.5,0.21,0.54,0.54,0.22,0.46,0.45,0.53,0.54,0.22,0.5,0.21,0.54,0.22,0.58,0.55,0.54,0.53,0.21,0.45,0.4,0.21,0.4,0.22,0.63,0.54,0.21,0.45,0.49,0.29,0.37,0.21,0.31,0.44,0.22,0.26,0.53,0.29,0.22,0.63,0.49,0.45,0.21,0.31,0.54,0.22,0.46,0.45,0.21,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> College of Medicine, King Saud Bin Abdulaziz University for Health Sci-</text>
   <text y="416.041" x="56.69,60.327,64.347,67.692,71.33,74.045,75.35,76.992,80.862,82.429,85.729,89.134,93.214,97.234,98.539,100.182,103.662,107.067,111.049,115.129,116.697,118.339,122.727,124.939,128.344,132.484,134.052,137.457,138.762" svgx:width="0.49,0.54,0.45,0.49,0.37,0.17,0.22,0.5,0.21,0.44,0.45,0.54,0.54,0.17,0.22,0.46,0.45,0.53,0.54,0.21,0.22,0.58,0.29,0.45,0.55,0.21,0.45,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">ences, Riyadh, Saudi Arabia. </text>
   <text y="413.041" x="140.406" svgx:width="0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:5.25px;stroke:none;">2</text>
   <text y="416.041" x="142.968,144.611,148.458,150.026,154.046,158.126,159.768,164.156,168.296,172.376,176.358,177.948,179.538,182.943,186.963,188.606,190.301,194.321,196.593,200.231,202.495,206.515,209.92,212.238,213.805,217.795,221.815,225.22,226.81,228.453,234.348,237.985,242.065,243.633,246.978,250.383,251.973,253.615,257.44,261.078,263.875,267.513,270.918,273.048,276.393,280.413" svgx:width="0.22,0.5,0.21,0.54,0.54,0.22,0.58,0.55,0.54,0.53,0.21,0.21,0.45,0.54,0.22,0.21,0.54,0.31,0.49,0.29,0.54,0.45,0.31,0.21,0.53,0.54,0.45,0.21,0.22,0.78,0.49,0.54,0.21,0.45,0.45,0.21,0.22,0.5,0.49,0.37,0.49,0.45,0.29,0.45,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> King Abdullah International Medical Research </text>
   <text y="425.041" x="56.696,60.926,64.563,68.583,70.856,74.493,76.368,77.673,79.316,83.186,84.753,88.053,91.458,95.538,99.558,100.863,102.506,105.986,109.391,113.373,117.453,119.021,120.663,125.051,127.263,130.668,134.808,136.376,139.781,141.086" svgx:width="0.57,0.49,0.54,0.31,0.49,0.29,0.17,0.22,0.5,0.21,0.44,0.45,0.54,0.54,0.17,0.22,0.46,0.45,0.53,0.54,0.21,0.22,0.58,0.29,0.45,0.55,0.21,0.45,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Center, Riyadh, Saudi Arabia. </text>
   <text y="422.041" x="142.724" svgx:width="0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:5.25px;stroke:none;">3</text>
   <text y="425.041" x="145.286,146.928,148.623,152.643,154.916,158.553,162.573,165.371,166.938,170.276,173.913,175.556,179.801,183.206,185.336,188.973,190.616,195.513,199.151,203.291,206.696,209.102,211.42,217.562,221.2,225.22,227.537,228.842,230.485,234.332,235.9,239.92,244.0,245.642,250.03,254.17,258.25,262.232,263.822,267.227,270.25,271.817,274.84" svgx:width="0.22,0.21,0.54,0.31,0.49,0.54,0.37,0.21,0.45,0.49,0.22,0.57,0.45,0.29,0.49,0.22,0.65,0.49,0.55,0.45,0.29,0.31,0.82,0.49,0.54,0.31,0.17,0.22,0.5,0.21,0.54,0.54,0.22,0.58,0.55,0.54,0.53,0.21,0.45,0.4,0.21,0.4,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> Intensive Care Department, King Abdulaziz </text>
   <text y="434.041" x="56.696,62.591,66.228,70.308,71.876,75.221,78.626,80.216,81.858,86.133,87.701,90.101,93.146,94.451,96.093,98.823,100.128,104.936,106.241,107.883,111.671,115.601,118.818,120.461,124.121,127.781,131.441,135.101,138.761,140.066,141.708,145.578,147.146,150.446,153.851,157.931,161.951,163.593,167.253,170.913,174.573,178.233,181.893,183.198,184.841,188.321,191.726,195.708,199.788,201.356,202.998,207.386,209.598,213.003,217.143,218.711,222.116,223.421" svgx:width="0.78,0.49,0.54,0.21,0.45,0.45,0.21,0.22,0.57,0.21,0.31,0.44,0.17,0.22,0.5,0.17,0.67,0.17,0.22,0.5,0.53,0.43,0.22,0.49,0.49,0.49,0.49,0.49,0.17,0.22,0.5,0.21,0.44,0.45,0.54,0.54,0.22,0.49,0.49,0.49,0.49,0.49,0.17,0.22,0.46,0.45,0.53,0.54,0.21,0.22,0.58,0.29,0.45,0.55,0.21,0.45,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Medical City, P.O. Box 22490, Riyadh 11426, Saudi Arabia. </text>
   <text y="431.041" x="225.057" svgx:width="0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:5.25px;stroke:none;">4</text>
   <text y="434.041" x="227.619,229.262,230.957,234.977,237.774,240.092,241.659,243.977,247.959,250.232,253.869,255.512,259.502,261.467,263.109,267.834,271.472,274.877,276.467,278.784,282.804" svgx:width="0.22,0.21,0.54,0.37,0.31,0.21,0.31,0.53,0.31,0.49,0.22,0.53,0.26,0.22,0.63,0.49,0.45,0.21,0.31,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> Institute of Health </text>
   <text y="443.041" x="56.694,60.264,64.254,65.844,67.412,70.899,74.199,75.842,81.737,85.142,89.162,92.567,96.647,100.284,106.427,110.064,114.084,116.402,118.044,121.449,125.469,129.549,131.192,134.656,138.046,141.451,143.041,147.023,150.428,152.746,154.313,158.303,162.323,163.628,165.271,169.966,173.986,175.553,178.891,182.528,184.741,187.538,189.106,191.506,194.806,196.448,200.438,202.403,203.732,206.724,210.714,212.844,216.834,220.854,223.127,226.982,228.287,229.614,232.607,236.597,238.727,242.717,246.737,249.009,252.864,254.169,255.812,260.057,263.462,267.482,270.887,274.967,278.372,279.677" svgx:width="0.5,0.53,0.21,0.21,0.45,0.44,0.22,0.78,0.45,0.54,0.45,0.54,0.49,0.82,0.49,0.54,0.31,0.22,0.45,0.54,0.54,0.22,0.47,0.45,0.45,0.21,0.53,0.45,0.31,0.21,0.53,0.54,0.17,0.22,0.63,0.54,0.21,0.45,0.49,0.29,0.37,0.21,0.31,0.44,0.22,0.53,0.26,0.22,0.47,0.53,0.29,0.53,0.54,0.31,0.53,0.17,0.22,0.47,0.53,0.29,0.53,0.54,0.31,0.53,0.17,0.22,0.57,0.45,0.54,0.45,0.54,0.45,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Policy Management and Evaluation, University of Toronto, Toronto, Canada. </text>
   <text y="449.041" x="56.693" svgx:width="0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:5.25px;stroke:none;">5</text>
   <text y="452.041" x="59.255,60.897,65.795,69.432,73.572,76.977,79.385,81.702,87.845,91.482,95.502,97.82,99.462,103.452,105.417,107.06,111.335,113.6,115.167,117.485,119.052,122.397,125.802,127.392,129.035,133.28,136.685,138.815,142.452,144.095,149.99,153.627,157.707,159.275,162.62,164.187,168.207,171.77,173.075,174.717,178.197,182.18,186.2,190.145,193.445,197.585,199.715,203.705,207.695,210.867,212.51,217.235,221.225,224.022,228.162,229.73,232.047,235.452,236.96,238.265,239.592,242.585,246.575,248.705,252.695,256.715,258.987,262.842,264.147,265.79,270.035,273.44,277.46,280.865,284.945,288.35,289.655" svgx:width="0.22,0.65,0.49,0.55,0.45,0.29,0.31,0.82,0.49,0.54,0.31,0.22,0.53,0.26,0.22,0.57,0.29,0.21,0.31,0.21,0.45,0.45,0.21,0.22,0.57,0.45,0.29,0.49,0.22,0.78,0.49,0.54,0.21,0.45,0.21,0.54,0.49,0.17,0.22,0.46,0.53,0.54,0.54,0.44,0.55,0.29,0.53,0.53,0.42,0.22,0.63,0.53,0.37,0.55,0.21,0.31,0.45,0.21,0.17,0.22,0.47,0.53,0.29,0.53,0.54,0.31,0.53,0.17,0.22,0.57,0.45,0.54,0.45,0.54,0.45,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> Department of Critical Care Medicine, Sunnybrook Hospital, Toronto, Canada. </text>
   <text y="458.041" x="56.693" svgx:width="0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:5.25px;stroke:none;">6</text>
   <text y="461.041" x="59.255,60.897,65.795,69.432,73.572,76.977,79.385,81.702,87.845,91.482,95.502,97.82,99.462,103.452,105.417,107.06,112.954,116.592,120.672,122.239,125.584,127.152,131.172,134.734,136.039,137.682,141.162,145.144,149.164,153.109,156.409,160.549,162.679,166.669,170.659,173.832,175.474,180.199,184.189,186.987,191.127,192.694,195.012,198.417,199.924,201.229,202.557,205.549,209.539,211.669,215.659,219.679,221.952,225.807,227.112,228.754,232.999,236.404,240.424,243.829,247.909,251.314,252.619" svgx:width="0.22,0.65,0.49,0.55,0.45,0.29,0.31,0.82,0.49,0.54,0.31,0.22,0.53,0.26,0.22,0.78,0.49,0.54,0.21,0.45,0.21,0.54,0.49,0.17,0.22,0.46,0.53,0.54,0.54,0.44,0.55,0.29,0.53,0.53,0.42,0.22,0.63,0.53,0.37,0.55,0.21,0.31,0.45,0.21,0.17,0.22,0.47,0.53,0.29,0.53,0.54,0.31,0.53,0.17,0.22,0.57,0.45,0.54,0.45,0.54,0.45,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> Department of Medicine, Sunnybrook Hospital, Toronto, Canada. </text>
   <text y="458.041" x="254.259" svgx:width="0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:5.25px;stroke:none;">7</text>
   <text y="461.041" x="256.821,258.464,263.361,266.999,271.139,274.544,276.951,279.209" svgx:width="0.22,0.65,0.49,0.55,0.45,0.29,0.31,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> Depart-</text>
   <text y="470.041" x="56.691,62.834,66.471,70.491,72.809,74.451,78.441,80.406,82.049,87.943,91.581,95.661,97.228,100.573,102.141,106.161,109.723,111.028,112.671,117.523,119.091,122.481,124.048,126.846,128.413,132.403,136.423,138.066,142.056,144.021,145.663,147.358,151.378,153.231,156.868,160.296,162.613,164.181,168.171,172.153,174.951,176.593,181.446,183.013,185.811,189.448,192.853,195.651,199.288,202.086,203.728,207.133,211.153,215.233,216.876,218.571,222.591,224.863,228.501,230.765,234.785,238.19,240.507,242.075,246.065,250.085,253.49,255.08,256.722,261.447,265.085,268.49,270.08,272.397,276.417,277.722" svgx:width="0.82,0.49,0.54,0.31,0.22,0.53,0.26,0.22,0.78,0.49,0.54,0.21,0.45,0.21,0.54,0.49,0.17,0.22,0.65,0.21,0.45,0.21,0.37,0.21,0.53,0.54,0.22,0.53,0.26,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.21,0.53,0.53,0.37,0.22,0.65,0.21,0.37,0.49,0.45,0.37,0.49,0.37,0.22,0.45,0.54,0.54,0.22,0.21,0.54,0.31,0.49,0.29,0.54,0.45,0.31,0.21,0.53,0.54,0.45,0.21,0.22,0.63,0.49,0.45,0.21,0.31,0.54,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">ment of Medicine, Division of Infectious Diseases and International Health, </text>
   <text y="479.041" x="56.691,61.386,65.406,66.974,70.311,73.949,76.161,78.959,80.526,82.926,86.226,87.868,91.858,93.823,95.204,98.954,100.521,102.666,106.686,108.254,112.274,113.841,117.246,118.889,122.406,125.751,129.771,133.761,137.751,139.341,140.984,144.974,146.939,148.581,154.476,158.114,162.194,163.761,167.106,168.674,172.694,176.256,177.561,179.204,183.479,187.499,190.904,193.176,194.766,198.756,201.074,203.346,206.984,209.781,213.171,214.739,216.329,217.919,221.481,222.786,224.166,227.534,231.921,233.226,234.869,239.564,243.044,247.431,248.736" svgx:width="0.63,0.54,0.21,0.45,0.49,0.29,0.37,0.21,0.31,0.44,0.22,0.53,0.26,0.22,0.51,0.21,0.29,0.54,0.21,0.54,0.21,0.45,0.22,0.46,0.45,0.54,0.53,0.53,0.21,0.22,0.53,0.26,0.22,0.78,0.49,0.54,0.21,0.45,0.21,0.54,0.49,0.17,0.22,0.57,0.54,0.45,0.29,0.21,0.53,0.31,0.31,0.49,0.37,0.45,0.21,0.21,0.21,0.49,0.17,0.22,0.51,0.58,0.17,0.22,0.63,0.46,0.58,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">University of Virginia School of Medicine, Charlottesville, VA, USA. </text>
   <text y="497.041" x="56.691,60.276,64.544,68.834,73.191,75.111,79.401" svgx:width="0.51,0.57,0.57,0.58,0.26,0.57,0.57" style="fill:rgb(0,0,0);font-family:MyriadPro-Semibold;font-size:7.5px;stroke:none;">Funding</text>
   <text y="506.041" x="56.691,61.476,65.466,69.486,73.049" svgx:width="0.64,0.53,0.54,0.49,0.17" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">None.</text>
   <text y="524.041" x="56.691,60.981,65.211,71.571,75.959,77.886,79.806,83.616,87.906,91.206,95.076,96.629,102.246,104.166,106.799,111.089,112.641,116.511,119.144,123.434,125.354,128.721,132.531,134.459,136.011,139.139,141.771,145.581,149.871,154.229,158.039,160.641,164.999" svgx:width="0.59,0.56,0.85,0.58,0.26,0.26,0.51,0.57,0.45,0.52,0.21,0.75,0.26,0.35,0.57,0.21,0.52,0.35,0.57,0.26,0.45,0.51,0.26,0.21,0.42,0.35,0.51,0.57,0.58,0.51,0.36,0.58,0.42" style="fill:rgb(0,0,0);font-family:MyriadPro-Semibold;font-size:7.5px;stroke:none;">Compliance with ethical standards</text>
   <text y="542.041" x="56.691,60.981,65.211,69.501,71.894,73.821,75.741,79.221,81.854,84.981,86.534,90.764,93.156,94.709,96.629,100.881,103.469,107.339,109.941,113.811,116.939" svgx:width="0.59,0.56,0.57,0.32,0.26,0.26,0.45,0.35,0.42,0.21,0.56,0.32,0.21,0.26,0.57,0.35,0.52,0.36,0.52,0.42,0.35" style="fill:rgb(0,0,0);font-family:MyriadPro-Semibold;font-size:7.5px;stroke:none;">Conflicts of interest</text>
   <text y="551.041" x="56.691,61.544,63.419,64.724,66.366,70.754,72.966,76.371,80.511,82.079,83.721,85.289,88.086,89.729,92.046,96.066,99.704,101.346,105.486,107.751,109.318,113.338,116.683,118.251,122.391,125.796,127.386,129.028,130.596,134.541,137.878,141.516,144.313,146.631,148.198,152.278,155.683,157.955,161.945,164.157,165.8,169.79,173.81,175.452,178.857,180.5,183.845,185.435,187.002,191.022,192.59,195.935,199.34,200.93,202.572,204.89,207.154,208.722,212.127,213.717,215.359,217.212,221.202,223.414,225.057,226.647,230.637,234.777,236.344,240.364,243.724,247.114,248.682,250.894,253.527,255.791,257.358,259.631,263.621,267.641,271.001,274.391,275.958,278.171" svgx:width="0.65,0.29,0.17,0.22,0.58,0.29,0.45,0.55,0.21,0.22,0.21,0.37,0.22,0.31,0.54,0.49,0.22,0.55,0.29,0.21,0.54,0.45,0.21,0.55,0.45,0.21,0.22,0.21,0.54,0.45,0.49,0.37,0.31,0.21,0.54,0.45,0.31,0.53,0.29,0.22,0.53,0.54,0.22,0.45,0.22,0.45,0.21,0.21,0.54,0.21,0.45,0.45,0.21,0.22,0.31,0.29,0.21,0.45,0.21,0.22,0.26,0.53,0.29,0.22,0.21,0.53,0.55,0.21,0.54,0.45,0.45,0.21,0.29,0.35,0.29,0.21,0.31,0.53,0.54,0.45,0.45,0.21,0.29,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Dr. Arabi is the principal investigator on a clinical trial for lopinavir/ritonavir </text>
   <text y="560.041" x="56.691,60.096,64.116,68.196,69.839,71.406,75.426,77.699,81.336,83.788,85.641,89.278,91.408,95.398,99.418,101.061,102.628,106.648,108.291,114.246,115.813,119.893,123.973,125.563,129.201,130.843,134.338,137.743,140.541,142.858,144.501,146.631,150.268,153.066,157.206,158.773,160.986,164.391,166.663,170.653,173.091,176.391,178.033,180.831,184.131,188.151,192.231,194.361,198.351,204.493,208.131,209.773,211.761,217.596,221.091,224.878,228.358,230.346,231.988,235.393,239.413,243.493,245.136,247.453,251.473,254.878,257.196,258.838,262.858,266.496,268.138,273.553,276.958,279.756,281.398,284.803" svgx:width="0.45,0.54,0.54,0.22,0.21,0.54,0.31,0.49,0.29,0.26,0.49,0.29,0.53,0.54,0.22,0.21,0.54,0.22,0.78,0.21,0.54,0.54,0.21,0.49,0.22,0.47,0.45,0.37,0.31,0.22,0.29,0.49,0.37,0.55,0.21,0.29,0.45,0.31,0.53,0.29,0.44,0.22,0.37,0.44,0.54,0.54,0.29,0.53,0.82,0.49,0.22,0.26,0.78,0.47,0.5,0.46,0.26,0.22,0.45,0.54,0.54,0.22,0.31,0.54,0.45,0.31,0.22,0.54,0.49,0.22,0.72,0.45,0.37,0.22,0.45,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">and interferon in Middle East respiratory syndrome (MERS) and that he was a </text>
   <text y="569.041" x="56.691,60.711,64.701,68.721,70.956,75.096,78.501,80.069,84.149,85.791,89.136,93.126,97.146,99.944,103.926,105.516,107.834,111.239,115.259,117.576,119.219,123.209,127.229,128.871,132.276,136.296,138.614,140.181,143.571,145.139,147.351,150.756,152.346,153.989,157.394,160.821,163.139,164.706,168.044,171.681,173.324,175.176,179.166,181.378,183.021,188.856,192.351,196.138,199.618,202.003,205.348,209.338,211.468,215.458,219.478,222.838,226.228,227.796,230.008,233.991,236.788,238.431,240.381,244.611,248.601,252.951,254.938,256.581,258.433,262.423,264.636,266.278,270.958,272.526,274.116,277.753,281.158,285.238" svgx:width="0.54,0.53,0.54,0.3,0.55,0.45,0.21,0.54,0.22,0.45,0.53,0.54,0.37,0.53,0.21,0.31,0.45,0.54,0.31,0.22,0.53,0.54,0.22,0.45,0.54,0.31,0.21,0.45,0.21,0.29,0.45,0.21,0.22,0.45,0.45,0.31,0.21,0.45,0.49,0.22,0.26,0.53,0.29,0.22,0.78,0.47,0.5,0.46,0.3,0.45,0.53,0.29,0.53,0.54,0.45,0.45,0.21,0.29,0.53,0.37,0.22,0.26,0.57,0.53,0.51,0.26,0.22,0.26,0.53,0.29,0.22,0.62,0.21,0.21,0.49,0.45,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">non-paid consultant on antiviral active for MERS-coronavirus (CoV) for Gilead </text>
   <text y="578.041" x="56.691,60.209,63.554,65.121,68.759,72.779,76.124,79.761,82.559,84.201,87.606,91.626,95.706,97.349,100.829,105.216,109.004,110.646,114.434,116.001,119.991,122.309,126.329,129.966,132.179,135.584,139.724,143.361,147.344,149.661,151.229,154.574,157.289,158.594,160.236,165.089,166.964,168.269,169.911,174.636,177.996,181.244,185.324,188.961,192.696,193.566,196.364,198.006,199.574,203.594,206.391,208.709,210.276,212.594,216.576,218.894,220.461,224.451,228.471,230.114,232.244,235.881,239.226,242.864,244.431,247.77,251.407,255.487,257.13,259.095,263.077,267.097,271.177,272.745,276.765,280.845" svgx:width="0.46,0.45,0.21,0.49,0.54,0.45,0.49,0.37,0.22,0.45,0.54,0.54,0.22,0.46,0.58,0.5,0.22,0.5,0.21,0.53,0.31,0.54,0.49,0.29,0.45,0.55,0.49,0.53,0.31,0.21,0.45,0.37,0.17,0.22,0.65,0.29,0.17,0.22,0.63,0.45,0.44,0.54,0.49,0.54,0.17,0.37,0.22,0.21,0.54,0.37,0.31,0.21,0.31,0.53,0.31,0.21,0.53,0.54,0.22,0.29,0.49,0.45,0.49,0.21,0.45,0.49,0.54,0.22,0.26,0.53,0.54,0.54,0.21,0.54,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Sciences and SAB Biotherapeutics. Dr. Hayden’s institution received funding </text>
   <text y="587.041" x="56.691,58.656,60.786,64.776,70.919,72.561,77.241,78.831,82.236,85.371,89.361,92.841,98.984,100.551,102.869,106.889,110.744,112.334,113.901,117.921,121.559,123.201,125.189,130.041,133.446,135.764,139.169,140.811,144.291,147.696,149.549,153.186,155.586,158.886,160.529,166.424,170.414,174.434,176.001,178.274,182.264,184.529,186.096,190.116,194.196,195.839,199.626,203.616,207.021,209.152,213.232,214.875,216.862,221.715,225.195,231.03,234.817,236.805,238.447,244.59,248.227,254.37,258.51,262.147,264.36,266.002,267.855,271.845,274.057" svgx:width="0.26,0.29,0.53,0.82,0.22,0.62,0.21,0.45,0.43,0.53,0.46,0.82,0.21,0.31,0.54,0.5,0.21,0.21,0.54,0.49,0.22,0.26,0.65,0.45,0.31,0.45,0.22,0.46,0.45,0.26,0.49,0.31,0.44,0.22,0.78,0.53,0.54,0.21,0.31,0.53,0.29,0.21,0.54,0.54,0.22,0.5,0.53,0.45,0.29,0.54,0.22,0.26,0.65,0.46,0.78,0.5,0.26,0.22,0.82,0.49,0.82,0.55,0.49,0.29,0.22,0.26,0.53,0.29,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">from GlaxoSmithKline (Data Safety Monitoring Board [DSMB] member for </text>
   <text y="596.041" x="56.691,58.259,62.279,65.909,69.891,73.529,77.549,80.571,83.976,85.619,87.831,91.236,95.256,99.336,103.326,109.469,111.036,113.999,117.636,121.716,124.101,127.446,131.436,135.456,137.773,139.903,143.893,145.483,147.073,150.711,154.791,156.433,158.751,161.016,162.583,165.988,167.578,169.221,171.208,175.056,179.616,183.688,185.676,187.663,188.968,190.611,194.841,198.478,200.068,201.658,203.976,206.241,207.808,211.798,215.818,217.461,219.448,224.301,227.781,233.616,237.403,239.046,242.391,246.411,249.816,251.383,253.596,255.238,257.091,261.081,263.293,264.936,266.503,270.523,274.153,278.136" svgx:width="0.21,0.54,0.48,0.53,0.49,0.54,0.4,0.45,0.22,0.29,0.45,0.54,0.54,0.53,0.82,0.21,0.4,0.49,0.54,0.3,0.45,0.53,0.54,0.31,0.29,0.53,0.21,0.21,0.49,0.54,0.22,0.31,0.29,0.21,0.45,0.21,0.22,0.26,0.5,0.57,0.47,0.26,0.26,0.17,0.22,0.57,0.49,0.21,0.21,0.31,0.29,0.21,0.53,0.54,0.22,0.26,0.65,0.46,0.78,0.5,0.22,0.45,0.54,0.45,0.21,0.29,0.22,0.26,0.53,0.29,0.22,0.21,0.54,0.48,0.53,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">influenza randomized-controlled trial [RCT]), Celltrion (DSMB chair for influ-</text>
   <text y="605.041" x="56.691,60.329,64.349,67.371,70.776,72.419,76.266,80.826,84.898,86.886,88.191,89.833,93.238,97.258,101.338,102.718,106.326,109.731,113.076,116.421,117.988,120.261,123.898,127.243,131.263,132.906,134.893,139.746,143.226,149.061,152.848,154.491,157.836,161.856,165.261,166.828,169.041,170.683,172.536,176.526,178.738,180.381,181.948,185.968,189.598,193.581,197.218,201.238,204.261,207.666,209.308,213.156,217.716,220.896,223.693,225.681,226.986,228.628,232.648,236.286,237.928,240.058,243.696,247.041,250.678,252.246,255.583,259.221,263.301,264.943,268.963,272.953,276.973,281.069" svgx:width="0.49,0.54,0.4,0.45,0.22,0.5,0.57,0.47,0.26,0.17,0.22,0.45,0.54,0.54,0.22,0.51,0.45,0.45,0.45,0.21,0.31,0.49,0.45,0.54,0.22,0.26,0.65,0.46,0.78,0.5,0.22,0.45,0.54,0.45,0.21,0.29,0.22,0.26,0.53,0.29,0.22,0.21,0.54,0.48,0.53,0.49,0.54,0.4,0.45,0.22,0.5,0.57,0.47,0.37,0.26,0.17,0.22,0.54,0.49,0.22,0.29,0.49,0.45,0.49,0.21,0.45,0.49,0.54,0.22,0.54,0.53,0.54,0.53,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">enza RCT), and Vaccitech (DSMB chair for influenza RCTs); he received hono-</text>
   <text y="614.041" x="56.691,58.904,62.309,64.574,66.141,69.546,71.189,73.154,75.284,79.274,85.416,86.796,92.751,96.741,99.014,100.604,104.684,106.326,111.051,114.689,118.094,119.684,122.001,126.021,127.664,132.696,134.841,138.921,142.326,146.346,147.914,150.936,154.341,156.659,158.226,162.216,166.236,167.879,169.836,173.181,177.171,181.191,183.989,187.971,189.561,191.879,195.284,199.304,201.621,203.264,207.254,211.274,212.916,214.484,218.504,222.134,226.116,229.754,233.774,236.796,240.201,241.844,245.249,249.269,253.349,254.991,258.629,264.771,268.409,270.554,274.574,276.141,280.161,284.241" svgx:width="0.29,0.45,0.29,0.21,0.45,0.22,0.26,0.29,0.53,0.82,0.22,0.82,0.53,0.29,0.21,0.54,0.22,0.63,0.49,0.45,0.21,0.31,0.54,0.22,0.67,0.29,0.54,0.45,0.54,0.21,0.4,0.45,0.31,0.21,0.53,0.54,0.22,0.26,0.45,0.53,0.54,0.37,0.53,0.21,0.31,0.45,0.54,0.31,0.22,0.53,0.54,0.22,0.21,0.54,0.48,0.53,0.49,0.54,0.4,0.45,0.22,0.45,0.54,0.54,0.22,0.49,0.82,0.49,0.29,0.54,0.21,0.54,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">raria from World Health Organization (consultant on influenza and emerging </text>
   <text y="623.041" x="56.691,60.081,61.649,63.861,67.266,68.856,70.499,72.066,76.086,77.939,81.576,85.003,87.321,88.888,92.878,96.898,99.696,101.683,103.326,106.731,110.751,114.831,116.473,118.791,122.811,126.448,128.091,132.786,136.806,138.373,141.711,145.348,147.561,150.358,151.926,154.326,157.626,159.268,163.258,165.223,166.866,171.253,172.843,176.248,180.388,183.793,189.936,193.341,194.983,196.971,200.488,203.833,205.401,209.038,213.058,215.376,216.943,220.573,223.918,225.561,229.873,233.953,237.343,238.911,241.708,245.698,248.136,251.436,253.078,256.866,260.856,264.261,266.391,270.471" svgx:width="0.45,0.21,0.29,0.45,0.21,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.21,0.53,0.54,0.37,0.26,0.22,0.45,0.54,0.54,0.22,0.31,0.54,0.49,0.22,0.63,0.54,0.21,0.45,0.49,0.29,0.37,0.21,0.31,0.44,0.22,0.53,0.26,0.22,0.58,0.21,0.45,0.55,0.45,0.82,0.45,0.22,0.26,0.46,0.45,0.21,0.49,0.54,0.31,0.21,0.48,0.45,0.22,0.58,0.54,0.45,0.21,0.37,0.53,0.29,0.44,0.22,0.5,0.53,0.45,0.29,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">viral infections) and the University of Alabama (Scientific Advisory Board </text>
   <text y="632.041" x="56.691,62.834,66.471,72.614,76.754,80.391,82.604,84.246,86.099,90.089,92.301,93.944,98.729,102.134,104.451,106.019,110.009,114.029,117.434,119.024,120.666,122.361,126.381,129.179,131.496,133.064,135.381,139.364,141.636,145.274,148.071,149.714,153.704,155.669,157.311,162.036,165.674,169.079,170.669,172.986,177.006,179.241,182.039,186.179,190.169,194.189,196.986,200.976,203.106,206.744,210.824,212.466,216.854,220.874,223.191,224.759,228.149,229.716,231.929,235.334,236.924,238.566,243.419,244.986,247.784,251.129,255.081,258.419,262.056,264.494,267.794,269.436,272.841,276.861,280.941" svgx:width="0.82,0.49,0.82,0.55,0.49,0.29,0.22,0.26,0.53,0.29,0.22,0.64,0.45,0.31,0.21,0.53,0.54,0.45,0.21,0.22,0.21,0.54,0.37,0.31,0.21,0.31,0.53,0.31,0.49,0.37,0.22,0.53,0.26,0.22,0.63,0.49,0.45,0.21,0.31,0.54,0.3,0.37,0.55,0.53,0.54,0.37,0.53,0.29,0.49,0.54,0.22,0.58,0.54,0.31,0.21,0.45,0.21,0.29,0.45,0.21,0.22,0.65,0.21,0.37,0.45,0.53,0.45,0.49,0.29,0.44,0.22,0.45,0.54,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">member for National Institutes of Health-sponsored Antiviral Discovery and </text>
   <text y="641.041" x="56.691,61.589,65.256,68.594,72.231,73.821,77.811,81.951,88.094,91.731,95.751,98.069,99.711,103.941,107.931,111.951,114.749,118.739,121.146,123.463,125.031,129.013,135.156,137.143,138.448,140.091,144.111,147.748,149.391,153.471,155.038,157.836,161.181,162.771,166.761,169.558,173.196,177.276,178.918,181.236,185.256,188.661,190.978,192.621,196.641,200.278,201.921,205.941,209.346,212.143,213.786,217.926,221.563,225.201,229.221,230.863,234.268,235.911,239.931,243.921,247.941,250.176,254.316,257.721,259.288,263.368,265.011,268.356,272.346,276.366,279.163,283.146,284.736,286.986" svgx:width="0.65,0.49,0.45,0.49,0.21,0.53,0.55,0.82,0.49,0.54,0.31,0.22,0.57,0.53,0.54,0.37,0.53,0.29,0.31,0.21,0.53,0.82,0.26,0.17,0.22,0.54,0.49,0.22,0.54,0.21,0.37,0.45,0.21,0.53,0.37,0.49,0.54,0.22,0.31,0.54,0.45,0.31,0.22,0.54,0.49,0.22,0.54,0.45,0.37,0.22,0.55,0.49,0.49,0.54,0.22,0.45,0.22,0.54,0.53,0.54,0.3,0.55,0.45,0.21,0.54,0.22,0.45,0.53,0.54,0.37,0.53,0.21,0.31,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Development Consortium); he disclosed that he has been a non-paid consult-</text>
   <text y="650.041" x="56.691,60.096,64.116,66.434,68.076,72.066,76.086,77.729,81.134,85.154,87.471,89.039,92.429,93.996,96.209,99.614,101.204,104.001,105.644,109.049,112.476,114.794,116.361,119.699,123.336,124.979,126.831,130.821,133.033,134.676,140.511,144.006,147.793,151.273,153.621,157.851,161.841,165.658,167.301,169.152,173.142,175.355,176.997,181.677,183.245,184.835,188.472,191.877,195.957,197.6,201.117,204.462,206.03,209.667,213.687,217.032,220.67,223.385,224.69,226.332,229.812,234.2,237.987,239.63,243.417,244.985,248.975,251.292,255.312,258.95,261.162,264.567,268.707,272.345,276.327,278.645,280.212,283.557,286.272,287.577" svgx:width="0.45,0.54,0.31,0.22,0.53,0.54,0.22,0.45,0.54,0.31,0.21,0.45,0.21,0.29,0.45,0.21,0.37,0.22,0.45,0.45,0.31,0.21,0.45,0.49,0.22,0.26,0.53,0.29,0.22,0.78,0.47,0.5,0.46,0.3,0.57,0.53,0.51,0.22,0.26,0.53,0.29,0.22,0.62,0.21,0.21,0.49,0.45,0.54,0.22,0.46,0.45,0.21,0.49,0.54,0.45,0.49,0.37,0.17,0.22,0.46,0.58,0.5,0.22,0.5,0.21,0.53,0.31,0.54,0.49,0.29,0.45,0.55,0.49,0.53,0.31,0.21,0.45,0.37,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">ant on antivirals active for MERS-CoV for Gilead Sciences, SAB Biotherapeutics, </text>
   <text y="659.041" x="56.691,60.096,64.116,68.196,69.839,73.664,77.301,81.381,85.019,89.039,92.676,94.806,98.796,102.816,104.121,105.764,109.169,113.189,117.269,118.911,120.763,124.753,126.966,128.608,134.751,138.733,140.323,142.641,144.208,148.348,149.938,153.576,155.218,158.563,162.553,168.696,172.836,176.241,180.261,181.828,185.466,188.263,189.906,193.896,197.916,199.558,201.126,205.146,208.776,212.758,216.396,220.416,223.438,226.843,228.486,230.803,234.823,238.461,240.673,244.078,248.218,251.856,255.838,258.156,259.723,263.068,265.866,267.171,268.813,273.088,274.656,278.736,282.141,284.353,287.758,289.063" svgx:width="0.45,0.54,0.54,0.22,0.5,0.49,0.54,0.49,0.54,0.49,0.29,0.53,0.54,0.17,0.22,0.45,0.54,0.54,0.22,0.26,0.53,0.29,0.22,0.82,0.53,0.21,0.31,0.21,0.55,0.21,0.49,0.22,0.45,0.53,0.82,0.55,0.45,0.54,0.21,0.49,0.37,0.22,0.53,0.54,0.22,0.21,0.54,0.48,0.53,0.49,0.54,0.4,0.45,0.22,0.31,0.54,0.49,0.29,0.45,0.55,0.49,0.53,0.31,0.21,0.45,0.37,0.17,0.22,0.57,0.21,0.54,0.45,0.29,0.45,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">and Regeneron, and for multiple companies on influenza therapeutics; Cidara, </text>
   <text y="668.041" x="56.691,60.171,64.191,65.759,69.749,73.769,77.759,81.779,83.346,84.651,86.294,89.811,93.448,97.513,99.081,101.293,105.276,107.991,109.296,110.938,114.343,118.363,122.443,124.086,126.216,129.853,132.515,135.808,140.841,144.702,148.842,150.41,154.4,156.042,160.062,163.422,166.76,170.397,172.04,178.182,181.587,185.667,189.305,190.947,194.292,198.312,201.717,203.982,205.55,207.867,211.272,215.412,217.002,220.64,222.282,225.627,229.617,233.637,235.955,238.22,239.787,243.927,247.91,250.227,251.795,255.785,259.805,262.602,264.245,266.517,270.507,272.149,274.467,278.487,282.124" svgx:width="0.46,0.54,0.21,0.53,0.54,0.53,0.54,0.21,0.17,0.22,0.46,0.49,0.54,0.21,0.29,0.53,0.37,0.17,0.22,0.45,0.54,0.54,0.22,0.29,0.49,0.37,0.47,0.67,0.5,0.55,0.21,0.53,0.22,0.54,0.45,0.45,0.49,0.22,0.82,0.45,0.54,0.49,0.22,0.45,0.54,0.45,0.29,0.21,0.31,0.45,0.55,0.21,0.49,0.22,0.45,0.53,0.54,0.31,0.29,0.21,0.55,0.53,0.31,0.21,0.53,0.54,0.37,0.22,0.31,0.53,0.22,0.31,0.54,0.49,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Shionogi, Seqirus, and resTORbio have made charitable contributions to the </text>
   <text y="677.041" x="56.691,59.901,63.891,66.021,70.101,71.744,76.469,79.874,81.441,83.759,85.326,88.731,92.751,94.394,99.426,101.691,105.831,109.851,113.256,117.276,120.681,124.761,128.398,130.041,133.446,137.466,141.546,143.188,146.706,150.051,154.071,158.061,162.051,163.641,165.283,167.136,171.126,173.338,174.981,179.001,180.568,183.366,185.008,188.353,192.343,196.363,199.161,203.143,204.733,207.051,208.618,212.638,216.718,218.361,220.678,222.246,228.388,232.026,233.331,234.973,238.453,242.473,244.041,248.031,252.051,256.041,260.061,261.628,263.271,266.676,270.696,274.776" svgx:width="0.46,0.53,0.29,0.54,0.22,0.63,0.45,0.21,0.31,0.21,0.45,0.54,0.22,0.67,0.29,0.55,0.54,0.45,0.54,0.45,0.54,0.49,0.22,0.45,0.54,0.54,0.22,0.46,0.45,0.54,0.53,0.53,0.21,0.22,0.26,0.53,0.29,0.22,0.54,0.21,0.37,0.22,0.45,0.53,0.54,0.37,0.53,0.21,0.31,0.21,0.54,0.54,0.22,0.31,0.21,0.82,0.49,0.17,0.22,0.46,0.54,0.21,0.53,0.54,0.53,0.54,0.21,0.22,0.45,0.54,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Ford Haitian Orphanage and School for his consulting time; Shionogi and </text>
   <text y="686.041" x="56.691,60.516,64.506,67.851,71.871,75.509,77.151,81.171,84.531,87.87,91.507,93.15,97.29,99.42,103.372,106.762,108.33,112.41,116.047,120.127,121.77,127.912,131.55,135.187,137.505,139.072,143.092,147.172,148.815,151.132,153.345,156.705,160.042,163.68,165.27,166.912,169.71,173.692,177.832,181.972,185.962,188.37,190.687" svgx:width="0.5,0.53,0.45,0.54,0.49,0.22,0.54,0.45,0.45,0.49,0.22,0.55,0.29,0.53,0.45,0.21,0.54,0.49,0.54,0.22,0.82,0.49,0.49,0.31,0.21,0.54,0.54,0.22,0.31,0.29,0.45,0.45,0.49,0.21,0.22,0.37,0.53,0.55,0.55,0.53,0.29,0.31,0.17" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Roche have provided meeting travel support.</text>
   <text y="95.525" x="304.724,310.606,316.611,322.77,325.603,328.425,332.895,338.931,344.369,348.469,350.189,354.659,356.739,363.816,369.759,373.487" svgx:width="0.58,0.58,0.6,0.28,0.27,0.43,0.59,0.53,0.38,0.26,0.43,0.2,0.69,0.58,0.37,0.53" style="fill:rgb(0,0,0);font-family:MyriadPro-Bold;font-size:10.3px;stroke:none;">Publisher’s Note</text>
   <text y="104.525" x="304.724,308.204,312.344,314.609,316.177,320.197,324.277,327.914,330.127,331.769,336.554,339.959,342.277,346.259,348.389,352.027,353.669,355.799,359.437,365.579,368.984,370.552,374.572,377.369,379.012,383.032,386.669,390.652,392.969,395.182,398.587,400.177,401.819,407.234,408.802,411.119,415.139,416.782,418.912,422.549,426.629,430.034,432.164,436.244,437.887,440.159,444.149,445.792,447.397,451.379,453.644,455.211,458.009,462.089,463.656,467.084,469.401,470.969,474.959,478.979,482.384,483.974,485.616,488.961,490.551,493.956,495.524,501.666,504.464,506.106,507.673,511.693,513.336,517.476,521.458,525.697" svgx:width="0.46,0.55,0.29,0.21,0.54,0.54,0.49,0.29,0.22,0.64,0.45,0.31,0.53,0.29,0.49,0.22,0.29,0.49,0.82,0.45,0.21,0.54,0.37,0.22,0.54,0.49,0.53,0.31,0.29,0.45,0.21,0.22,0.72,0.21,0.31,0.54,0.22,0.29,0.49,0.54,0.45,0.29,0.54,0.22,0.31,0.53,0.22,0.21,0.53,0.29,0.21,0.37,0.54,0.21,0.45,0.31,0.21,0.53,0.54,0.45,0.21,0.22,0.45,0.21,0.45,0.21,0.82,0.37,0.22,0.21,0.54,0.22,0.55,0.53,0.55,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Springer Nature remains neutral with regard to jurisdictional claims in pub-</text>
   <text y="113.525" x="304.724,306.314,307.882,310.679,314.699,318.337,322.417,324.059,330.202,333.607,337.747,340.544,342.187,345.592,349.612,353.692,355.334,356.902,360.922,363.719,366.037,367.604,369.922,373.904,376.222,377.789,381.779,385.799,389.204,390.794,392.437,395.842,401.564,403.154,404.722,408.127,410.444,412.012,416.002,420.022,422.737" svgx:width="0.21,0.21,0.37,0.54,0.49,0.54,0.22,0.82,0.45,0.55,0.37,0.22,0.45,0.54,0.54,0.22,0.21,0.54,0.37,0.31,0.21,0.31,0.53,0.31,0.21,0.53,0.54,0.45,0.21,0.22,0.45,0.76,0.21,0.21,0.45,0.31,0.21,0.53,0.54,0.37,0.17" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">lished maps and institutional affiliations.</text>
   <text y="131.525" x="304.724,308.789,312.547,315.862,319.619,321.374,324.907,328.664,332.894,334.447,336.037,339.884,343.732,345.322,350.519,353.977,356.414,360.531,364.799,368.556,371.009,372.599,376.446,380.294,384.141,387.989,389.579,391.169,392.759,397.259,400.574,403.889,407.646,411.914,414.351,418.109,422.339,423.891,425.481,429.329,433.176,434.766,437.541,441.156,445.319,449.451,453.066,455.706,459.239,460.829,464.676,468.524,472.371" svgx:width="0.54,0.5,0.45,0.5,0.23,0.48,0.5,0.56,0.21,0.21,0.51,0.51,0.21,0.69,0.45,0.33,0.55,0.57,0.5,0.33,0.21,0.51,0.51,0.51,0.51,0.21,0.21,0.21,0.61,0.45,0.45,0.5,0.57,0.33,0.5,0.56,0.21,0.21,0.51,0.51,0.21,0.37,0.48,0.56,0.55,0.48,0.33,0.47,0.21,0.51,0.51,0.51,0.51" style="fill:rgb(0,0,0);font-family:MyriadPro-Regular;font-size:7.5px;stroke:none;">Received: 20 October 2019 Accepted: 16 January 2020</text>
   <text y="140.525" x="304.724,308.602,312.734,317.002,318.772,320.527,323.497,327.659,331.417,335.647,337.237,341.354,345.517,347.287,349.042,353.204,356.962,358.514,360.104,363.952,367.799,369.389,372.809,376.567,380.834,383.287,387.419,391.034,393.674,397.207,398.797,402.644,406.492,410.339" svgx:width="0.53,0.55,0.57,0.24,0.23,0.4,0.56,0.5,0.56,0.21,0.55,0.56,0.24,0.23,0.56,0.5,0.21,0.21,0.51,0.51,0.21,0.49,0.5,0.57,0.33,0.55,0.48,0.33,0.47,0.21,0.51,0.51,0.51,0.51" style="fill:rgb(0,0,0);font-family:MyriadPro-Regular;font-size:7.5px;stroke:none;">Published online: 10 February 2020</text>
   <text y="177.522" x="304.724,309.014,312.884,315.194,319.064,321.667,325.537,329.827,333.126,336.996" svgx:width="0.57,0.52,0.32,0.52,0.36,0.52,0.57,0.45,0.52,0.42" style="fill:rgb(0,0,0);font-family:MyriadPro-Semibold;font-size:7.5px;stroke:none;">References</text>
   <text y="186.522" x="304.724,305.722,309.382,310.687,312.337,319.724,323.647,327.052,329.324,333.344,337.327,338.969,341.444,342.749,344.391,348.779,350.369,353.774,356.009,359.826,363.816,367.153,370.408,374.398,375.725,379.213,380.795,382.1,383.48,387.223,391.205,395.195,397.46,399.028,403.048,406.685,410.705,412.033,415.183,416.488,418.13,423.163,427.183,429.455,433.445,437.465,441.103,445.123,446.765,449.495,450.8,452.443,455.923,459.223,461.435,463.04,466.445,468.035,471.44,473.083,477.808,479.45,481.438,485.098,488.758,492.418,496.078,498.065,499.708,502.94,506.892,512.255,515.893,518.105" svgx:width="0.22,0.49,0.17,0.22,0.55,0.5,0.45,0.29,0.54,0.53,0.22,0.34,0.17,0.22,0.58,0.21,0.45,0.3,0.5,0.53,0.42,0.42,0.53,0.22,0.47,0.21,0.17,0.22,0.51,0.53,0.53,0.29,0.21,0.54,0.49,0.54,0.22,0.47,0.17,0.22,0.67,0.54,0.31,0.53,0.54,0.49,0.54,0.22,0.5,0.17,0.22,0.46,0.44,0.29,0.21,0.45,0.21,0.45,0.22,0.63,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.45,0.53,0.72,0.49,0.29,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 1. Karhu J, Ala-Kokko TI, Vuorinen T, Ohtonen P, Syrjala H (2014) Lower </text>
   <text y="195.522" x="319.724,321.854,325.492,328.289,332.429,333.997,336.209,339.614,341.887,345.877,348.314,351.614,353.256,355.574,357.786,361.191,364.619,366.936,368.579,371.969,373.536,375.749,379.731,382.529,384.171,387.801,391.821,395.901,397.469,401.489,405.569,408.366,410.009,411.576,415.596,417.239,423.381,427.019,430.364,434.384,437.789,441.809,443.376,446.721,450.126,451.716,453.306,456.606,458.248,461.586,465.224,469.243,471.561,473.129,474.719,478.124,480.396,484.034,488.113,489.756,493.896,497.301,499.618,501.186,504.824,508.844,511.161,513.958,515.601,521.016,522.583,524.901,528.921" svgx:width="0.29,0.49,0.37,0.55,0.21,0.29,0.45,0.31,0.53,0.29,0.44,0.22,0.31,0.29,0.45,0.45,0.31,0.22,0.45,0.21,0.29,0.53,0.37,0.22,0.48,0.54,0.54,0.21,0.54,0.54,0.37,0.22,0.21,0.54,0.22,0.82,0.49,0.45,0.54,0.45,0.54,0.21,0.45,0.45,0.21,0.21,0.44,0.22,0.45,0.49,0.54,0.31,0.21,0.21,0.45,0.31,0.49,0.54,0.22,0.55,0.45,0.31,0.21,0.49,0.54,0.31,0.37,0.22,0.72,0.21,0.31,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">respiratory tract virus findings in mechanically ventilated patients with </text>
   <text y="204.522" x="319.724,322.522,326.189,329.527,333.164,335.294,338.932,340.574,343.919,347.909,354.052,360.194,364.177,368.197,369.764,372.164,375.464,377.699,381.104,384.449,388.514,392.497,394.064,396.194,399.832,403.912,405.554,409.694,413.714,417.352,421.334,427.477,431.467,435.487,437.054,440.459,441.764,443.407,447.682,449.272,450.839,454.859,456.502,458.197,462.217,464.069,467.707,471.134,473.451,475.094,479.946,481.514,484.311,485.954,489.614,493.274,494.579,498.239,501.899,505.649,509.309" svgx:width="0.37,0.49,0.45,0.49,0.29,0.49,0.22,0.45,0.53,0.82,0.82,0.53,0.54,0.21,0.31,0.44,0.3,0.45,0.45,0.54,0.53,0.21,0.29,0.49,0.54,0.22,0.55,0.54,0.49,0.53,0.82,0.53,0.54,0.21,0.45,0.17,0.22,0.57,0.21,0.21,0.54,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.22,0.65,0.21,0.37,0.22,0.49,0.49,0.17,0.49,0.49,0.5,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">severe community-acquired pneumonia. Clin Infect Dis 59:62–70</text>
   <text y="213.522" x="304.724,305.722,309.382,310.687,312.337,319.724,324.449,327.854,330.652,333.989,337.979,339.569,343.649,345.292,347.766,349.071,350.714,354.194,355.799,359.789,363.869,365.436,369.456,373.536,375.179,381.014,382.319,383.961,387.531,391.521,395.541,397.131,398.774,402.673,403.978,405.62,409.85,413.84,417.83,421.085,424.723,426.365,430.64,431.945,433.588,438.418,441.718,444.995,448.295,449.938,453.784,458.059,459.702,461.689,465.349,469.009,472.669,476.329,478.317,479.644,483.102,487.122,490.759,492.402,494.532,498.522,500.112,503.749,505.392,509.382,511.347,512.989,517.009,520.992,527.134,530.539,534.559" svgx:width="0.22,0.49,0.17,0.22,0.55,0.63,0.45,0.37,0.45,0.53,0.21,0.54,0.22,0.34,0.17,0.22,0.46,0.21,0.53,0.54,0.21,0.54,0.54,0.22,0.78,0.17,0.22,0.5,0.53,0.54,0.21,0.22,0.5,0.17,0.22,0.57,0.53,0.53,0.42,0.49,0.22,0.57,0.17,0.22,0.63,0.44,0.4,0.44,0.22,0.5,0.57,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.47,0.54,0.49,0.22,0.29,0.53,0.21,0.49,0.22,0.53,0.26,0.22,0.54,0.53,0.82,0.45,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 2. Hasvold J, Sjoding M, Pohl K, Cooke C, Hyzy RC (2016) The role of human </text>
   <text y="222.522" x="319.724,325.867,329.504,331.822,335.227,339.367,343.387,347.024,351.007,357.149,361.102,364.492,366.059,368.272,372.254,375.052,376.694,378.262,382.282,383.924,386.242,390.262,393.899,395.542,398.887,401.152,402.719,405.037,406.604,409.949,413.354,414.944,416.534,419.834,421.477,423.044,424.634,426.224,427.867,431.272,435.352,439.334,440.924,443.242,444.884,449.024,452.429,454.747,456.314,459.952,463.972,466.289,467.594,469.237,471.824,473.467,477.742,480.007,481.574,483.892,485.534,489.779,493.184,495.314,498.952,500.594,504.254,507.914,509.219,512.879,516.539,520.199,523.949,527.609,531.269" svgx:width="0.82,0.49,0.31,0.45,0.55,0.54,0.49,0.53,0.82,0.53,0.45,0.21,0.29,0.53,0.37,0.22,0.21,0.54,0.22,0.31,0.54,0.49,0.22,0.45,0.29,0.21,0.31,0.21,0.45,0.45,0.21,0.21,0.44,0.22,0.21,0.21,0.21,0.22,0.45,0.54,0.53,0.21,0.31,0.22,0.55,0.45,0.31,0.21,0.49,0.54,0.31,0.17,0.22,0.34,0.22,0.57,0.29,0.21,0.31,0.22,0.57,0.45,0.29,0.49,0.22,0.49,0.49,0.17,0.49,0.49,0.49,0.5,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">metapneumovirus in the critically ill adult patient. J Crit Care 31:233–237</text>
   <text y="231.522" x="304.724,305.722,309.382,310.687,312.337,319.724,323.729,327.712,333.854,335.444,338.849,340.492,344.879,346.184,347.827,353.722,357.359,363.502,365.069,367.867,371.887,373.529,377.527,381.914,383.219,384.862,390.757,394.162,397.799,401.782,403.912,407.549,409.762,411.404,417.239,418.544,420.187,423.974,427.379,429.651,433.289,436.086,437.729,443.564,444.869,446.511,452.429,457.844,461.249,465.389,468.794,470.436,473.166,474.471,476.114,480.501,482.091,483.981,487.004,490.363,495.779,499.409,503.474,505.116,507.703,512.091,513.396,515.039,519.936,523.573,527.594" svgx:width="0.22,0.49,0.17,0.22,0.55,0.54,0.53,0.82,0.21,0.45,0.22,0.58,0.17,0.22,0.78,0.49,0.82,0.21,0.37,0.54,0.22,0.54,0.58,0.17,0.22,0.78,0.45,0.49,0.53,0.29,0.49,0.29,0.22,0.78,0.17,0.22,0.5,0.45,0.31,0.49,0.37,0.22,0.78,0.17,0.22,0.78,0.72,0.45,0.55,0.45,0.22,0.5,0.17,0.22,0.58,0.21,0.3,0.47,0.45,0.72,0.48,0.54,0.22,0.34,0.58,0.17,0.22,0.65,0.49,0.54,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 3. Zumla A, Memish ZA, Maeurer M, Bates M, Mwaba P, Al-Tawfiq JA, Den-</text>
   <text y="240.522" x="319.724,323.744,325.312,329.332,333.412,335.054,339.967,345.771,347.076,348.719,353.444,356.804,360.051,364.131,367.769,371.789,373.431,376.896,381.576,382.881,384.524,389.249,393.231,394.799,396.441,401.294,404.774,406.416,408.404,412.064,415.724,419.384,423.044,425.031,426.674,430.169,436.311,439.949,442.094,446.113,447.681,451.701,455.781,457.423,461.443,465.396,468.733,472.371,473.961,475.603,479.008,483.028,487.108,488.751,492.156,496.176,498.493,500.061,506.203,507.771,511.116,513.246,517.236,521.376,522.943,526.348,527.938" svgx:width="0.54,0.21,0.54,0.54,0.22,0.65,0.82,0.17,0.22,0.63,0.45,0.44,0.54,0.49,0.54,0.22,0.46,0.62,0.17,0.22,0.63,0.53,0.21,0.22,0.65,0.46,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.47,0.82,0.49,0.29,0.54,0.21,0.54,0.54,0.22,0.54,0.53,0.45,0.49,0.21,0.22,0.45,0.54,0.54,0.22,0.45,0.54,0.31,0.21,0.82,0.21,0.45,0.29,0.53,0.55,0.21,0.45,0.21,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">ning DW, Hayden FG, Hui DS (2014) Emerging novel and antimicrobial-</text>
   <text y="249.522" x="319.724,321.854,325.492,328.289,329.857,332.654,334.972,338.377,342.397,344.714,346.357,348.487,352.124,354.922,359.062,360.629,362.842,366.247,368.519,372.509,374.947,378.247,379.889,382.207,384.419,387.824,391.252,393.569,395.212,396.779,400.799,402.652,406.289,409.717,412.034,413.602,417.592,421.612,424.409,425.714,427.357,431.377,435.044,440.459,442.102,446.182,448.394,452.377,456.457,458.099,462.179,465.847,469.184,472.822,474.412,478.402,482.542,488.684,492.322,496.342,498.659,500.302,503.707,507.727,511.807" svgx:width="0.29,0.49,0.37,0.21,0.37,0.31,0.45,0.54,0.31,0.22,0.29,0.49,0.37,0.55,0.21,0.29,0.45,0.31,0.53,0.29,0.44,0.22,0.31,0.29,0.45,0.45,0.31,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.21,0.53,0.54,0.37,0.17,0.22,0.54,0.49,0.72,0.22,0.54,0.29,0.53,0.54,0.22,0.54,0.49,0.45,0.49,0.21,0.53,0.55,0.82,0.49,0.54,0.31,0.22,0.45,0.54,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">resistant respiratory tract infections: new drug development and </text>
   <text y="258.522" x="319.724,322.042,326.062,329.699,331.912,335.317,339.457,343.094,347.077,349.394,350.962,354.307,355.949,359.939,364.079,366.397,367.964,371.954,375.974,378.689,379.994,381.637,384.997,388.402,392.422,395.767,399.404,401.722,403.364,405.059,409.079,410.932,414.569,417.997,420.314,421.957,426.809,428.377,431.174,432.817,436.477,440.137,441.442,445.102,448.762,452.422,456.082,459.832,463.492,467.152,470.812" svgx:width="0.31,0.54,0.49,0.29,0.45,0.55,0.49,0.53,0.31,0.21,0.45,0.22,0.53,0.55,0.31,0.21,0.53,0.54,0.37,0.17,0.22,0.45,0.45,0.54,0.45,0.49,0.31,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.22,0.65,0.21,0.37,0.22,0.49,0.49,0.17,0.49,0.49,0.49,0.49,0.5,0.49,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">therapeutic options. Lancet Infect Dis 14:1136–1149</text>
   <text y="267.522" x="304.724,305.722,309.382,310.687,312.337,319.724,324.449,327.854,331.874,333.727,337.364,338.954,341.212,343.559,348.277,352.267,355.672,359.752,363.389,365.032,369.659,370.964,372.607,378.501,381.906,383.474,389.616,393.606,397.626,399.269,404.054,405.359,407.001,411.899,413.466,419.609,423.246,425.459,427.101,431.489,432.794,434.436,438.074,440.391,442.034,445.439,447.029,448.671,453.059,454.701,458.841,462.861,466.266,469.064,472.701,474.344,478.004,482.009,483.314,484.956,487.168,490.573,494.593,498.673,502.663,508.806,510.373,513.336,516.973,520.971,522.276" svgx:width="0.22,0.49,0.17,0.22,0.55,0.63,0.45,0.54,0.26,0.49,0.21,0.31,0.3,0.62,0.53,0.45,0.54,0.49,0.22,0.65,0.17,0.22,0.78,0.45,0.21,0.82,0.53,0.54,0.22,0.64,0.17,0.22,0.64,0.21,0.82,0.49,0.29,0.22,0.58,0.17,0.22,0.49,0.31,0.22,0.45,0.21,0.22,0.58,0.22,0.55,0.54,0.45,0.37,0.49,0.22,0.49,0.55,0.17,0.22,0.29,0.45,0.54,0.54,0.53,0.82,0.21,0.4,0.49,0.54,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 4. Hanfelt-Goade D, Maimon N, Nimer A, et al A phase 2b, randomized, </text>
   <text y="276.522" x="319.724,323.804,327.794,331.777,335.917,337.507,341.339,343.574,347.714,349.304,350.871,354.891,358.889,360.194,361.836,365.976,367.566,370.971,374.316,377.954,382.094,386.189,388.574,391.919,395.909,399.929,402.246,404.376,408.366,409.956,411.546,415.184,419.264,420.906,423.224,425.489,427.056,430.461,432.051,433.694,437.684,439.649,441.291,445.431,447.561,451.199,453.996,457.401,459.674,463.626,467.016,468.584,470.796,472.439,474.389,479.069,482.549,484.784,488.444,492.104,495.764,499.424,501.411,502.716,504.359,507.764,509.406,513.426,517.379,520.716,524.354,525.944" svgx:width="0.54,0.53,0.53,0.55,0.21,0.49,0.3,0.55,0.21,0.21,0.54,0.54,0.17,0.22,0.55,0.21,0.45,0.45,0.49,0.55,0.53,0.3,0.45,0.53,0.54,0.31,0.29,0.53,0.21,0.21,0.49,0.54,0.22,0.31,0.29,0.21,0.45,0.21,0.22,0.53,0.26,0.22,0.55,0.29,0.49,0.37,0.45,0.31,0.53,0.45,0.21,0.29,0.22,0.26,0.62,0.46,0.3,0.49,0.49,0.49,0.49,0.26,0.17,0.22,0.45,0.22,0.54,0.53,0.45,0.49,0.21,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">double-blind, placebo-controlled trial of presatovir (GS-5806), a novel </text>
   <text y="285.522" x="319.724,323.714,325.927,329.332,330.922,332.564,334.777,337.574,340.964,342.607,344.572,348.554,351.352,352.919,356.909,360.929,362.572,364.139,368.159,372.179,373.747,377.887,379.454,381.727,385.717,387.592,388.897,390.539,392.391,396.381,398.594,400.236,402.554,406.574,410.211,411.854,414.171,416.301,419.939,423.344,425.661,431.804,435.441,439.461,441.779,443.421,447.411,449.376,451.018,453.148,456.786,459.583,463.724,465.291,467.504,470.909,473.181,477.171,479.608,482.908,484.55,487.348,490.648,494.668,498.155,501.455,503.773,505.34,508.745,510.335,511.978,515.368,516.935,519.148,523.13,525.928" svgx:width="0.53,0.29,0.45,0.21,0.22,0.29,0.37,0.45,0.22,0.26,0.53,0.37,0.21,0.53,0.54,0.22,0.21,0.54,0.54,0.21,0.55,0.21,0.31,0.53,0.29,0.17,0.22,0.26,0.53,0.29,0.22,0.31,0.54,0.49,0.22,0.31,0.29,0.49,0.45,0.31,0.82,0.49,0.54,0.31,0.22,0.53,0.26,0.22,0.29,0.49,0.37,0.55,0.21,0.29,0.45,0.31,0.53,0.29,0.44,0.22,0.37,0.44,0.54,0.45,0.44,0.31,0.21,0.45,0.21,0.22,0.45,0.21,0.29,0.53,0.37,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">oral rsv fusion inhibitor, for the treatment of respiratory syncytial virus </text>
   <text y="294.522" x="319.724,321.712,325.499,328.979,333.329,335.317,336.959,338.527,342.547,344.189,348.209,352.199,354.997,359.137,360.704,363.022,366.427,368.017,369.584,372.547,376.184,380.264,381.907,385.312,389.392,393.374,394.964,397.282,400.079,401.722,406.109,412.252,415.889,418.154,419.721,423.066,426.471,430.491,431.819,435.276,439.296,443.286,445.499,448.904,452.249,453.816,457.161,458.804,462.321,466.311,469.656,471.224,474.861,477.261,480.561,482.204,485.864,489.524,493.184,496.844,498.486,500.054,504.074,506.345,509.983,512.248,516.268,519.673,521.99,523.558,527.548,531.568,534.973,536.563" svgx:width="0.26,0.5,0.46,0.51,0.26,0.22,0.21,0.54,0.22,0.54,0.53,0.37,0.55,0.21,0.31,0.45,0.21,0.21,0.4,0.49,0.54,0.22,0.45,0.54,0.53,0.21,0.31,0.37,0.22,0.58,0.82,0.49,0.29,0.21,0.45,0.45,0.54,0.22,0.47,0.54,0.53,0.29,0.45,0.45,0.21,0.45,0.22,0.46,0.53,0.45,0.21,0.49,0.31,0.44,0.22,0.49,0.49,0.49,0.49,0.22,0.21,0.54,0.31,0.49,0.29,0.54,0.45,0.31,0.21,0.53,0.54,0.45,0.21,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">(RSV) in hospitalized adults American Thoracic Society 2018 international </text>
   <text y="303.522" x="319.724,323.069,327.059,331.079,332.932,336.569,338.699,342.337,346.357,349.702,353.264,354.569,356.211,359.691,363.096,367.116,368.759,373.611,375.179,378.816,382.896,386.751,388.056,389.699,393.359,397.019,400.679,404.339,405.644,407.286,410.691,414.831,417.629,419.946,422.159,425.564,428.99,431.308,432.95,437.338,440.998,444.658,448.318" svgx:width="0.45,0.53,0.54,0.26,0.49,0.29,0.49,0.54,0.45,0.49,0.17,0.22,0.46,0.45,0.54,0.22,0.65,0.21,0.49,0.54,0.53,0.17,0.22,0.49,0.49,0.49,0.49,0.17,0.22,0.45,0.55,0.37,0.31,0.29,0.45,0.45,0.31,0.22,0.58,0.49,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">conference, San Diego, 2018: abstract A4457</text>
   <text y="312.522" x="304.724,305.722,309.382,310.687,312.337,319.724,324.464,327.869,334.012,335.579,339.599,343.694,345.929,350.316,352.581,354.711,358.664,361.911,365.901,367.544,371.931,375.426,376.731,378.374,383.054,387.036,390.674,392.938,395.068,398.705,400.836,404.826,406.469,412.304,415.664,416.969,418.611,424.506,427.851,432.096,435.501,437.909,440.226,444.171,447.471,449.113,452.593,453.898,455.541,459.433,462.838,468.981,470.548,472.678,476.316,479.338,481.543,485.166,488.803,492.823,496.461,500.541,503.946,506.743,508.386,512.773,514.078,515.721,519.081,520.671,524.076,530.219" svgx:width="0.22,0.49,0.17,0.22,0.55,0.62,0.45,0.82,0.21,0.54,0.53,0.3,0.58,0.29,0.29,0.53,0.44,0.53,0.22,0.58,0.47,0.17,0.22,0.62,0.53,0.49,0.29,0.29,0.49,0.29,0.53,0.22,0.78,0.45,0.17,0.22,0.78,0.45,0.57,0.45,0.29,0.31,0.54,0.44,0.22,0.46,0.17,0.22,0.5,0.45,0.82,0.21,0.29,0.49,0.4,0.3,0.51,0.49,0.54,0.49,0.54,0.45,0.37,0.22,0.58,0.17,0.22,0.45,0.21,0.45,0.82,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 5. Gamino-Arroyo AE, Guerrero ML, McCarthy S, Ramirez-Venegas A, Llam-</text>
   <text y="321.522" x="319.724,323.714,326.512,329.917,332.714,335.062,339.801,343.206,344.796,346.386,349.791,351.921,356.001,359.991,361.634,365.339,366.644,368.286,373.026,376.431,378.021,379.589,383.609,387.689,391.784,394.019,397.259,399.471,402.876,406.956,410.361,412.003,416.391,417.696,419.338,425.233,429.223,431.353,434.991,439.011,443.106,445.341,448.836,451.633,455.773,457.341,461.361,465.351,468.148,471.553,473.196,476.676,477.981,479.623,483.448,487.438,489.028,493.108,496.513,500.533,502.768,507.156,509.368,512.773,516.853,520.843,524.863,526.131,529.296,530.601" svgx:width="0.53,0.37,0.45,0.37,0.3,0.62,0.45,0.21,0.21,0.45,0.29,0.54,0.53,0.22,0.5,0.17,0.22,0.62,0.45,0.21,0.21,0.54,0.54,0.53,0.3,0.46,0.29,0.45,0.54,0.45,0.22,0.58,0.17,0.22,0.78,0.53,0.29,0.49,0.54,0.53,0.3,0.47,0.37,0.55,0.21,0.54,0.53,0.37,0.45,0.22,0.46,0.17,0.22,0.5,0.53,0.21,0.54,0.45,0.54,0.3,0.58,0.29,0.45,0.54,0.53,0.54,0.22,0.5,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">osas-Gallardo B, Galindo-Fraga A, Moreno-Espinosa S, Roldan-Aragon Y, </text>
   <text y="330.522" x="319.724,324.112,326.324,329.729,333.712,335.317,339.411,341.646,347.541,351.179,352.769,356.406,360.426,364.506,368.144,371.166,372.809,375.283,376.588,378.23,382.955,386.938,390.958,393.755,397.895,401.533,403.678,407.758,411.395,413.608,415.25,418.73,420.035,421.678,423.373,427.513,430.918,433.183,435.395,438.8,441.147,445.865,449.855,453.875,456.897,460.302,461.892,465.53,468.552,469.932,473.405,474.71,476.352,482.247,485.652,488.059,490.377,491.944,495.964,499.602,502.624,504.859,508.092,512.082,516.222,519.859,522.882,524.525,527.0,528.305" svgx:width="0.58,0.29,0.45,0.53,0.21,0.53,0.3,0.78,0.49,0.21,0.49,0.54,0.54,0.49,0.4,0.22,0.34,0.17,0.22,0.63,0.53,0.54,0.37,0.55,0.49,0.29,0.54,0.49,0.29,0.22,0.46,0.17,0.22,0.21,0.55,0.45,0.29,0.29,0.45,0.3,0.62,0.53,0.54,0.4,0.45,0.21,0.49,0.4,0.22,0.51,0.17,0.22,0.78,0.45,0.29,0.31,0.21,0.54,0.49,0.4,0.3,0.45,0.53,0.55,0.49,0.4,0.22,0.34,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Araujo-Melendez J, Hunsberger S, Ibarra-Gonzalez V, Martinez-Lopez J, </text>
   <text y="339.522" x="319.724,324.464,327.869,329.999,333.344,334.912,338.317,340.552,344.939,348.959,353.039,355.252,358.657,362.737,366.374,368.017,371.377,375.764,377.069,378.712,382.634,386.039,390.179,394.162,396.959,400.979,404.969,408.314,409.957,414.682,415.987,417.629,422.354,426.344,427.934,429.524,433.191,436.491,438.134,442.859,446.624,448.266,450.854,452.729,454.034,455.676,459.156,465.298,469.288,470.878,473.676,477.013,478.581,481.378,483.021,488.856,493.131,494.436,496.078,499.866,503.848,505.416,508.438,510.673,514.213,517.618,519.208,522.614,525.958,527.526,531.516,534.313" svgx:width="0.62,0.45,0.29,0.45,0.21,0.45,0.3,0.58,0.54,0.54,0.29,0.45,0.54,0.49,0.22,0.45,0.58,0.17,0.22,0.5,0.45,0.55,0.53,0.37,0.54,0.53,0.45,0.22,0.63,0.17,0.22,0.63,0.53,0.21,0.21,0.49,0.44,0.22,0.63,0.5,0.22,0.34,0.29,0.17,0.22,0.46,0.82,0.53,0.21,0.37,0.42,0.21,0.37,0.22,0.78,0.57,0.17,0.22,0.5,0.53,0.21,0.4,0.3,0.5,0.45,0.21,0.45,0.45,0.21,0.53,0.37,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Garcia-Andrade LA, Kapushoc H, Holley HP Jr, Smolskis MC, Ruiz-Palacios </text>
   <text y="348.522" x="319.724,324.404,330.239,331.544,333.187,336.974,340.612,342.179,346.259,349.897,351.487,353.129,355.717,360.442,361.747,363.389,369.284,372.922,376.139,377.707,381.052,385.042,386.684,390.179,396.322,399.959,402.104,406.124,407.692,411.712,415.792,417.434,419.129,423.149,425.002,428.639,432.066,434.384,435.951,439.941,443.924,446.721,448.364,453.216,454.784,457.581,461.219,464.624,467.421,471.059,473.856,475.499,479.773,481.363,482.931,486.951,488.518,491.863,495.268,496.858,498.501,502.326,505.964,508.761,512.398,515.804,517.934,521.279,525.299" svgx:width="0.62,0.78,0.17,0.22,0.5,0.49,0.21,0.54,0.49,0.21,0.22,0.34,0.63,0.17,0.22,0.78,0.49,0.43,0.21,0.45,0.53,0.22,0.47,0.82,0.49,0.29,0.54,0.21,0.54,0.54,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.21,0.53,0.53,0.37,0.22,0.65,0.21,0.37,0.49,0.45,0.37,0.49,0.37,0.22,0.57,0.21,0.21,0.54,0.21,0.45,0.45,0.21,0.22,0.5,0.49,0.37,0.49,0.45,0.29,0.45,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">GM, Beigel JH, Mexico Emerging Infectious Diseases Clinical Research </text>
   <text y="357.522" x="319.724,324.509,326.152,328.139,331.799,335.459,339.119,342.779,344.767,346.409,349.934,355.657,359.002,362.407,365.894,369.194,370.837,374.242,378.262,382.342,383.984,386.782,390.187,392.039,395.677,398.077,401.377,403.019,407.009,408.974,410.617,414.637,416.204,418.522,421.927,424.889,428.819,432.037,435.442,439.462,441.029,445.109,448.747,450.389,451.957,455.977,457.619,461.024,465.104,469.184,470.752,473.069,474.637,478.627,482.647,484.289,486.562,490.552,492.194,494.992,497.309,500.714,504.734,508.814,512.219,514.349,518.429,520.072,524.062,526.027" svgx:width="0.64,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.47,0.76,0.45,0.45,0.45,0.44,0.22,0.45,0.54,0.54,0.22,0.37,0.45,0.26,0.49,0.31,0.44,0.22,0.53,0.26,0.22,0.54,0.21,0.31,0.45,0.4,0.53,0.43,0.45,0.54,0.21,0.54,0.49,0.22,0.21,0.54,0.22,0.45,0.54,0.54,0.21,0.31,0.21,0.53,0.54,0.22,0.31,0.53,0.22,0.37,0.31,0.45,0.54,0.54,0.45,0.29,0.54,0.22,0.53,0.26,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">N (2019) Efficacy and safety of nitazoxanide in addition to standard of </text>
   <text y="366.522" x="319.724,323.069,326.474,328.604,332.242,333.884,335.737,339.727,341.939,343.582,345.899,349.919,353.557,355.199,357.517,359.646,363.284,366.689,369.006,375.149,378.786,382.806,385.124,386.766,390.756,392.721,394.364,397.161,400.828,404.165,407.803,409.933,413.57,415.213,418.618,421.963,425.945,428.218,431.855,433.498,435.627,439.265,442.062,446.202,447.77,449.982,453.387,455.66,459.65,462.087,465.387,467.03,468.597,470.187,471.777,475.797,479.435,482.232,484.947,486.252,487.895,492.17,493.76,495.327,499.347,500.99,502.685,506.704,508.557,512.195,515.621,517.939,519.581,524.434,526.001,528.799" svgx:width="0.45,0.45,0.29,0.49,0.22,0.26,0.53,0.29,0.22,0.31,0.54,0.49,0.22,0.31,0.29,0.49,0.45,0.31,0.82,0.49,0.54,0.31,0.22,0.53,0.26,0.22,0.37,0.49,0.45,0.49,0.29,0.49,0.22,0.45,0.45,0.53,0.31,0.49,0.22,0.29,0.49,0.37,0.55,0.21,0.29,0.45,0.31,0.53,0.29,0.44,0.22,0.21,0.21,0.21,0.54,0.49,0.37,0.37,0.17,0.22,0.57,0.21,0.21,0.54,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.22,0.65,0.21,0.37,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">care for the treatment of severe acute respiratory illness. Clin Infect Dis </text>
   <text y="375.522" x="319.724,323.384,327.044,328.349,332.009,335.669,339.329,342.989,346.739,350.399,354.059,357.719" svgx:width="0.49,0.49,0.17,0.49,0.49,0.49,0.49,0.5,0.49,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">69:1903–1911</text>
   <text y="384.522" x="304.724,305.722,309.382,310.687,312.337,319.724,323.512,327.149,328.717,332.797,336.434,338.024,339.667,342.254,346.979,348.284,349.927,354.712,358.117,364.259,365.902,370.627,375.352,376.657,378.299,382.612,386.692,390.097,396.239,399.037,400.679,404.444,407.804,409.109,410.752,414.599,416.811,420.216,424.349,426.666,428.309,432.696,434.001,435.644,437.339,441.358,444.703,448.341,449.721,455.871,459.231,460.536,462.178,465.673,467.263,469.498,473.421,476.826,482.968,486.373,488.811,492.111,493.753,497.233,500.713,502.018,503.661,507.141,508.708,514.851,517.648,519.291,523.61,527.885" svgx:width="0.22,0.49,0.17,0.22,0.55,0.5,0.49,0.21,0.54,0.49,0.21,0.22,0.34,0.63,0.17,0.22,0.64,0.45,0.82,0.22,0.63,0.63,0.17,0.22,0.58,0.54,0.45,0.82,0.37,0.22,0.5,0.45,0.17,0.22,0.5,0.29,0.45,0.54,0.31,0.22,0.58,0.17,0.22,0.21,0.54,0.45,0.49,0.22,0.82,0.45,0.17,0.22,0.47,0.21,0.3,0.5,0.45,0.82,0.45,0.29,0.44,0.22,0.46,0.46,0.17,0.22,0.46,0.21,0.82,0.37,0.22,0.58,0.57,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 6. Beigel JH, Nam HH, Adams PL, Krafft A, Ince WL, El-Kamary SS, Sims AC </text>
   <text y="393.522" x="319.724,321.712,325.372,329.032,332.692,336.352,338.339,339.982,344.294,348.374,351.764,355.169,359.189,362.534,366.171,368.969,370.611,372.179,376.199,377.841,379.971,383.609,386.406,390.546,392.114,394.326,397.731,400.004,403.994,406.431,409.731,411.374,414.764,416.331,418.544,422.526,425.324,426.966,429.284,433.304,436.941,439.154,442.559,446.699,450.336,454.319,456.636,458.204,461.549,464.346,471.846,475.251,476.894,483.036,486.674,490.311,492.629,494.196,498.216,502.296,503.939,506.069,509.706,513.846,517.836,520.244,522.561,524.204,526.169,528.299,532.289,538.431" svgx:width="0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.58,0.54,0.45,0.45,0.54,0.45,0.49,0.37,0.22,0.21,0.54,0.22,0.29,0.49,0.37,0.55,0.21,0.29,0.45,0.31,0.53,0.29,0.44,0.22,0.45,0.21,0.29,0.53,0.37,0.22,0.31,0.54,0.49,0.29,0.45,0.55,0.49,0.53,0.31,0.21,0.45,0.37,1.0,0.45,0.22,0.82,0.49,0.49,0.31,0.21,0.54,0.54,0.22,0.29,0.49,0.55,0.53,0.29,0.31,0.22,0.26,0.29,0.53,0.82,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">(2019) Advances in respiratory virus therapeutics—a meeting report from </text>
   <text y="402.522" x="319.724,322.042,326.062,329.699,331.342,335.002,337.319,341.339,342.982,344.549,347.347,348.914,351.352,354.742,356.384,360.772,364.792,367.109,368.677,372.067,373.634,375.847,379.252,380.842,382.484,387.164,389.294,393.284,397.267,401.407,403.049,406.394,410.384,414.404,416.257,419.894,422.024,425.662,429.682,433.027,436.589,437.894,439.537,443.924,447.944,450.262,451.829,455.219,456.787,458.999,462.404,463.994,465.637,469.462,473.099,475.897,477.539,481.199,484.859,488.519,489.824,493.484,497.144,500.894,504.554" svgx:width="0.31,0.54,0.49,0.22,0.49,0.31,0.54,0.22,0.21,0.37,0.21,0.29,0.45,0.22,0.58,0.54,0.31,0.21,0.45,0.21,0.29,0.45,0.21,0.22,0.62,0.29,0.53,0.53,0.55,0.22,0.45,0.53,0.54,0.26,0.49,0.29,0.49,0.54,0.45,0.49,0.17,0.22,0.58,0.54,0.31,0.21,0.45,0.21,0.29,0.45,0.21,0.22,0.5,0.49,0.37,0.22,0.49,0.49,0.49,0.17,0.49,0.49,0.5,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">the 6th isirv Antiviral Group conference. Antiviral Res 167:45–67</text>
   <text y="411.522" x="304.724,305.722,309.382,310.687,312.337,319.724,325.589,329.572,331.889,335.909,339.892,342.157,343.724,345.367,348.847,353.527,354.832,356.212,359.834,363.472,367.492,370.859,374.264,376.537,380.174,382.972,386.377,390.397,392.039,395.519,396.824,398.467,404.384,407.684,409.274,412.912,415.709,417.352,421.117,424.904,426.209,427.852,431.084,434.722,438.712,442.732,446.137,448.267,452.347,453.914,456.149,459.937,463.574,467.212,468.854,471.329,472.634,474.277,478.664,480.254,481.897,485.751,489.771,493.753,499.168,502.573,504.141,506.458,508.026,510.238,511.566,515.023,518.503,519.808" svgx:width="0.22,0.49,0.17,0.22,0.55,0.78,0.53,0.31,0.54,0.53,0.29,0.21,0.22,0.46,0.62,0.17,0.22,0.51,0.49,0.54,0.42,0.45,0.31,0.49,0.37,0.45,0.54,0.22,0.46,0.17,0.22,0.78,0.44,0.21,0.49,0.37,0.22,0.5,0.5,0.17,0.22,0.45,0.49,0.53,0.54,0.45,0.29,0.54,0.21,0.3,0.5,0.49,0.49,0.22,0.34,0.17,0.22,0.58,0.21,0.22,0.5,0.54,0.53,0.72,0.45,0.21,0.31,0.21,0.29,0.22,0.47,0.46,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 7. Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Al Khuwaitir TS, </text>
   <text y="420.522" x="319.724,324.112,325.702,327.344,333.239,336.644,342.787,346.769,350.789,352.432,356.819,358.124,359.767,364.154,368.174,372.127,375.517,378.922,383.002,384.569,387.869,391.274,392.917,397.304,400.034,401.339,402.982,407.526,410.549,413.571,415.139,418.161,420.396,424.184,427.589,431.571,437.714,441.794,445.199,447.605,449.923,453.943,457.58,459.793,461.435,464.93,466.235,467.878,471.665,475.07,478.708,481.73,483.373,487.648,488.953,490.595,494.383,497.788,500.585,503.383,507.02,509.338,511.655,513.223,514.865,520.7,522.005" svgx:width="0.58,0.21,0.22,0.78,0.45,0.82,0.53,0.54,0.22,0.58,0.17,0.22,0.58,0.54,0.53,0.45,0.45,0.54,0.21,0.44,0.45,0.22,0.58,0.5,0.17,0.22,0.58,0.4,0.4,0.21,0.4,0.3,0.5,0.45,0.53,0.82,0.54,0.45,0.29,0.31,0.54,0.49,0.29,0.22,0.47,0.17,0.22,0.5,0.45,0.49,0.4,0.22,0.57,0.17,0.22,0.5,0.45,0.37,0.37,0.49,0.31,0.31,0.21,0.22,0.78,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Al Mamun A, Anovadiya AP, Azziz-Baumgartner E, Baez C, Bassetti M, </text>
   <text y="429.522" x="319.724,323.512,327.149,331.102,334.492,336.059,339.404,341.047,344.752,346.057,347.699,351.487,355.124,357.531,359.849,361.416,364.214,367.559,371.579,373.221,376.926,378.231,379.874,383.661,387.651,391.671,397.814,401.219,403.484,405.051,409.071,410.714,412.296,413.601,415.244,419.031,423.021,426.974,430.274,431.916,435.704,437.009,438.651,442.439,446.428,448.641,450.246,453.651,455.886,460.273,464.414,468.396,470.803,473.075,477.065,478.445,482.263,486.988,488.293,489.935,493.723,497.705,499.85,503.87,510.013,513.418,517.438,521.458,523.1,527.825,529.13" svgx:width="0.5,0.49,0.53,0.45,0.21,0.45,0.22,0.5,0.17,0.22,0.5,0.49,0.29,0.31,0.21,0.37,0.45,0.54,0.22,0.5,0.17,0.22,0.5,0.53,0.54,0.82,0.45,0.29,0.21,0.54,0.22,0.21,0.17,0.22,0.5,0.53,0.53,0.44,0.22,0.5,0.17,0.22,0.5,0.53,0.29,0.21,0.45,0.3,0.58,0.55,0.53,0.29,0.31,0.53,0.22,0.51,0.63,0.17,0.22,0.5,0.53,0.29,0.54,0.82,0.45,0.54,0.54,0.22,0.63,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Beovic B, Bertisch B, Bonmarin I, Booy R, Borja-Aburto VH, Burgmann H, </text>
   <text y="438.522" x="319.724,323.969,327.374,331.364,333.007,336.712,338.017,339.659,343.904,347.309,349.574,351.786,355.191,357.509,360.914,362.504,365.909,367.551,370.026,371.331,372.974,377.87,381.508,385.528,389.548,393.538,395.128,401.27,402.913,405.5,408.65,409.955,411.598,416.495,420.485,426.627,428.195,432.215,436.294,440.277,443.915,446.937,448.579,452.06,455.847,457.152,458.794,463.647,467.63,471.035,473.442,475.715,479.352,480.995,484.017,488.405,489.71,491.352,496.205,500.187,504.327,508.347,512.3,515.69,517.925,521.817,525.222,528.245" svgx:width="0.57,0.45,0.53,0.22,0.5,0.17,0.22,0.57,0.45,0.29,0.29,0.45,0.31,0.45,0.21,0.45,0.22,0.34,0.17,0.22,0.65,0.49,0.54,0.54,0.53,0.21,0.82,0.22,0.34,0.47,0.17,0.22,0.65,0.53,0.82,0.21,0.54,0.54,0.53,0.49,0.4,0.22,0.46,0.5,0.17,0.22,0.65,0.53,0.45,0.29,0.31,0.49,0.22,0.5,0.58,0.17,0.22,0.65,0.53,0.55,0.54,0.53,0.45,0.3,0.5,0.45,0.4,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Cao B, Carratala J, Denholm JT, Dominguez SR, Duarte PA, Dubnov-Raz </text>
   <text y="447.522" x="319.724,324.404,325.709,327.352,330.817,334.162,338.182,341.542,344.932,348.337,350.601,352.866,354.434,357.839,359.481,365.316,366.621,368.264,371.361,374.766,378.786,382.424,384.014,385.604,389.009,390.651,394.131,395.436,397.079,401.819,405.224,409.214,410.856,414.899,416.204,417.846,422.563,426.2,428.413,431.818,433.948,438.028,439.595,443.615,445.258,447.988,449.293,450.935,455.615,457.183,460.588,464.608,468.628,472.265,473.855,475.445,478.85,480.493,486.328,487.633,489.275,493.955,497.938,502.078,506.218,509.855,511.445,514.243,515.885,519.365,520.67" svgx:width="0.62,0.17,0.22,0.47,0.45,0.54,0.45,0.45,0.45,0.29,0.29,0.21,0.45,0.22,0.78,0.17,0.22,0.46,0.45,0.54,0.49,0.21,0.21,0.45,0.22,0.46,0.17,0.22,0.62,0.45,0.53,0.22,0.54,0.17,0.22,0.62,0.49,0.29,0.45,0.29,0.54,0.21,0.54,0.22,0.5,0.17,0.22,0.62,0.21,0.45,0.54,0.54,0.49,0.21,0.21,0.45,0.22,0.78,0.17,0.22,0.62,0.53,0.55,0.55,0.49,0.21,0.37,0.22,0.46,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">G, Echavarria M, Fanella S, Gao Z, Gerardin P, Giannella M, Gubbels S, </text>
   <text y="456.522" x="319.724,324.449,328.087,330.359,334.499,338.137,340.282,344.362,346.004,348.479,349.784,351.427,353.009,357.089,358.679,362.317,365.114,366.682,370.087,372.884,374.527,378.914,382.274,383.579,385.222,389.947,393.937,398.017,401.654,403.867,405.509,409.274,413.999,415.304,416.947,421.672,425.654,427.297,431.392,432.697,434.339,435.922,438.719,440.309,443.714,449.857,451.499,456.352,459.502,460.807,462.449,465.037,466.604,472.747,476.384,480.404,484.042,487.064,488.707,494.542,497.248,498.553,500.196,504.118,507.523,511.543,515.623,519.261,522.898,524.488,526.131,530.518,531.823" svgx:width="0.63,0.49,0.29,0.55,0.49,0.29,0.54,0.22,0.34,0.17,0.22,0.21,0.54,0.21,0.49,0.37,0.21,0.45,0.37,0.22,0.58,0.45,0.17,0.22,0.63,0.53,0.54,0.49,0.29,0.22,0.5,0.63,0.17,0.22,0.63,0.53,0.22,0.55,0.17,0.22,0.21,0.37,0.21,0.45,0.82,0.22,0.67,0.47,0.17,0.22,0.34,0.21,0.82,0.49,0.54,0.49,0.4,0.22,0.78,0.46,0.17,0.22,0.5,0.45,0.54,0.54,0.49,0.49,0.21,0.22,0.58,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Herberg J, Iglesias AL, Hoger PH, Hu X, Islam QT, Jimenez MF, Kandeel A, </text>
   <text y="465.522" x="319.724,323.542,327.179,328.747,330.352,333.314,336.951,339.164,341.961,343.604,348.284,349.589,351.231,355.086,359.106,362.511,364.101,365.669,367.259,368.826,370.469,375.194,376.499,378.141,381.989,386.009,387.576,391.656,395.676,397.993,399.636,405.471,406.776,408.418,412.153,416.136,420.216,424.206,425.848,429.748,431.053,432.696,436.431,440.413,443.211,446.233,450.253,451.821,455.458,457.746,460.768,462.411,467.091,468.396,470.038,473.773,477.756,480.778,486.921,490.326,494.346,495.988,497.571,498.876,500.518,504.253,509.668,513.073,517.093,518.736,523.078,528.913,530.218" svgx:width="0.5,0.49,0.21,0.21,0.4,0.49,0.29,0.37,0.22,0.62,0.17,0.22,0.5,0.54,0.45,0.21,0.21,0.21,0.21,0.22,0.63,0.17,0.22,0.5,0.54,0.21,0.54,0.54,0.31,0.22,0.78,0.17,0.22,0.5,0.53,0.54,0.53,0.22,0.5,0.17,0.22,0.5,0.53,0.37,0.4,0.54,0.21,0.49,0.29,0.4,0.22,0.62,0.17,0.22,0.5,0.53,0.4,0.82,0.45,0.54,0.22,0.21,0.17,0.22,0.5,0.72,0.45,0.54,0.22,0.58,0.78,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Keijzers G, Khalili H, Knight M, Kudo K, Kusznierz G, Kuzman I, Kwan AM, </text>
   <text y="474.522" x="319.724,324.112,330.254,331.822,335.842,339.479,341.122,342.704,346.064,347.369,349.012,352.372,355.777,359.797,363.877,367.514,371.534,375.172,379.252,383.332,386.969,389.182,390.824,394.319,395.624,397.267,400.627,404.032,408.052,411.419,414.824,417.037,420.442,424.462,426.029,427.672,431.407,435.112,436.417,438.059,441.292,444.929,448.919,450.187,453.929,457.409,458.714,460.357,463.717,465.284,469.304,472.558,476.548,478.191,481.978,483.283,484.926,488.286,489.853,493.836,495.478,498.208,499.513,501.156,507.051,510.456,514.536,517.941,521.961,525.366,527.683" svgx:width="0.58,0.82,0.21,0.54,0.49,0.22,0.21,0.45,0.17,0.22,0.45,0.45,0.54,0.54,0.49,0.54,0.49,0.54,0.54,0.49,0.29,0.22,0.47,0.17,0.22,0.45,0.45,0.54,0.42,0.45,0.29,0.45,0.54,0.21,0.22,0.5,0.5,0.17,0.22,0.45,0.49,0.53,0.22,0.5,0.46,0.17,0.22,0.45,0.21,0.54,0.42,0.53,0.22,0.5,0.17,0.22,0.45,0.21,0.53,0.22,0.5,0.17,0.22,0.78,0.45,0.54,0.45,0.54,0.45,0.31,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Amine IL, Langenegger E, Lankarani KB, Leo YS, Linko R, Liu P, Madanat </text>
   <text y="483.522" x="319.724,322.432,323.737,325.379,331.274,334.634,337.882,341.977,344.212,350.107,354.097,358.117,360.389,364.027,366.157,370.147,371.789,375.284,376.589,378.232,384.127,387.472,392.189,395.827,399.464,401.677,403.319,407.707,409.012,410.654,416.549,420.187,426.329,427.897,430.694,434.714,436.357,440.399,441.704,443.347,449.242,452.879,455.197,458.602,462.622,464.264,468.944,470.249,471.892,477.847,479.414,482.759,486.097,487.664,491.302,495.322,498.959,500.602,504.989,506.294,507.937,513.892,515.459,518.797,520.364,523.709,525.352,529.979,531.284" svgx:width="0.46,0.17,0.22,0.78,0.45,0.44,0.53,0.3,0.78,0.53,0.54,0.31,0.49,0.29,0.53,0.22,0.47,0.17,0.22,0.78,0.45,0.62,0.49,0.49,0.29,0.22,0.58,0.17,0.22,0.78,0.49,0.82,0.21,0.37,0.54,0.22,0.54,0.17,0.22,0.78,0.49,0.31,0.45,0.54,0.22,0.62,0.17,0.22,0.78,0.21,0.45,0.42,0.21,0.49,0.54,0.49,0.22,0.58,0.17,0.22,0.78,0.21,0.42,0.21,0.45,0.22,0.65,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">F, Mayo-Montero E, McGeer A, Memish Z, Metan G, Mickiene A, Mikic D, </text>
   <text y="492.522" x="319.724,325.619,329.609,333.629,337.649,339.292,342.982,347.662,348.967,350.609,356.504,360.494,362.706,366.111,370.191,371.759,373.401,377.789,379.094,380.736,385.626,388.926,395.069,398.474,402.553,405.913,411.328,414.733,416.376,419.106,420.411,422.053,427.086,428.676,430.243,433.633,437.038,438.681,444.516,448.011,449.316,450.958,455.991,459.013,462.381,465.786,469.806,471.448,477.283,478.588,480.231,483.771,487.176,489.306,492.943,496.28,500.3,501.943,506.57,507.875,509.518,513.058,516.463,520.445,522.035,523.678,529.513,530.818" svgx:width="0.78,0.53,0.54,0.54,0.22,0.5,0.62,0.17,0.22,0.78,0.53,0.29,0.45,0.54,0.21,0.22,0.58,0.17,0.22,0.64,0.44,0.82,0.45,0.54,0.45,0.72,0.45,0.22,0.5,0.17,0.22,0.67,0.21,0.21,0.45,0.45,0.22,0.78,0.47,0.17,0.22,0.67,0.4,0.42,0.45,0.54,0.22,0.78,0.17,0.22,0.5,0.45,0.29,0.49,0.42,0.54,0.22,0.65,0.17,0.22,0.5,0.45,0.53,0.21,0.22,0.78,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Mohn KG, Moradi A, Nymadawa P, Oliva ME, Ozkan M, Parekh D, Paul M, </text>
   <text y="501.522" x="319.724,323.294,327.284,328.874,332.279,335.624,338.797,340.439,343.904,346.634,347.939,349.582,353.474,356.879,359.197,363.217,364.859,368.647,373.034,374.339,375.982,379.807,383.797,387.877,390.142,391.709,395.789,399.772,403.409,406.432,408.074,412.462,417.187,418.492,420.134,423.614,427.019,429.284,431.414,435.404,439.387,441.352,442.994,446.489,450.195,451.5,453.143,456.66,460.298,463.703,465.293,468.93,470.573,474.893,479.168,480.473,482.115,485.633,489.27,491.677,493.949,497.939,502.019,506.002,507.592,509.182,512.587,514.852,516.419,520.439,524.519,527.924,531.944,533.587,537.292,538.597" svgx:width="0.5,0.53,0.21,0.45,0.45,0.42,0.22,0.46,0.5,0.17,0.22,0.5,0.45,0.31,0.54,0.22,0.5,0.58,0.17,0.22,0.5,0.53,0.54,0.29,0.21,0.54,0.53,0.49,0.4,0.22,0.58,0.63,0.17,0.22,0.46,0.45,0.29,0.29,0.53,0.53,0.26,0.22,0.47,0.5,0.17,0.22,0.46,0.49,0.45,0.21,0.49,0.22,0.58,0.57,0.17,0.22,0.46,0.49,0.29,0.31,0.53,0.54,0.53,0.21,0.21,0.45,0.29,0.21,0.54,0.54,0.45,0.54,0.22,0.5,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Polack FP, Rath BA, Rodriguez AH, Sarrouf EB, Seale AC, Sertogullarindan B, </text>
   <text y="510.522" x="319.724,323.204,324.772,328.837,332.819,336.457,338.024,340.237,343.642,345.284,351.119,356.954,358.259,359.902,363.382,366.719,368.849,372.487,374.744,376.979,382.874,386.279,390.299,391.867,395.504,397.776,399.366,403.356,404.999,407.474,408.779,410.421,413.901,416.174,419.811,423.951,427.971,431.376,435.396,437.039,439.746,441.051,442.379,445.401,448.806,450.396,453.801,455.931,459.569,462.741,464.384,467.879,469.184,470.511,473.534,476.939,480.959,485.039,486.682,489.269,495.074,496.379,497.707,500.699,504.689,506.332,510.067,513.967,515.272,516.6,519.592,523.582,525.847,527.977,531.614,534.412" svgx:width="0.46,0.21,0.54,0.53,0.49,0.21,0.29,0.45,0.22,0.78,0.78,0.17,0.22,0.46,0.42,0.29,0.49,0.31,0.3,0.78,0.45,0.54,0.21,0.49,0.29,0.21,0.53,0.22,0.34,0.17,0.22,0.46,0.31,0.49,0.55,0.54,0.45,0.54,0.22,0.46,0.17,0.22,0.47,0.45,0.21,0.45,0.29,0.49,0.42,0.22,0.47,0.17,0.22,0.47,0.45,0.54,0.54,0.22,0.34,0.82,0.17,0.22,0.47,0.53,0.22,0.5,0.5,0.17,0.22,0.47,0.53,0.29,0.29,0.49,0.37,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Siqueira MM, Skret-Magierlo J, Stephan F, Talarek E, Tang JW, To KK, Torres </text>
   <text y="519.522" x="319.724,324.112,325.417,326.744,329.737,333.727,335.939,339.922,343.942,345.584,349.064,353.789,355.094,356.422,359.609,361.822,365.227,369.247,370.889,375.517,376.822,378.464,383.159,386.407,390.044,393.382,394.949,396.276,399.764,405.599,406.904,408.284,411.891,415.296,419.316,420.959,424.964,430.326,434.316,435.906,437.549,441.936,443.241,444.621,448.229,451.634,455.616,459.696,462.134,465.434,466.813,472.618,473.923,475.303,479.053,480.621,484.701,490.843,494.248,496.461,497.788,500.938,502.243,503.511,506.863,510.853,514.108,518.098,520.416,523.821,525.463,529.363,532.513,533.818" svgx:width="0.58,0.17,0.22,0.47,0.53,0.29,0.53,0.54,0.22,0.46,0.63,0.17,0.22,0.47,0.29,0.45,0.54,0.22,0.65,0.17,0.22,0.63,0.44,0.49,0.42,0.21,0.22,0.47,0.78,0.17,0.22,0.51,0.45,0.54,0.22,0.54,0.72,0.53,0.21,0.22,0.58,0.17,0.22,0.51,0.45,0.53,0.54,0.29,0.44,0.22,0.82,0.17,0.22,0.51,0.21,0.54,0.82,0.45,0.29,0.22,0.47,0.17,0.22,0.5,0.53,0.42,0.53,0.31,0.45,0.22,0.5,0.47,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">A, Torun SH, Tran D, Uyeki TM, Van Zwol A, Vaudry W, Vidmar T, Yokota RT, </text>
   <text y="528.522" x="319.724,323.767,327.172,329.302,333.292,337.372,341.362,345.344,346.934,348.502,352.582,354.149,356.947,358.589,361.319,362.624,364.267,365.962,369.907,373.244,376.882,379.679,381.997,383.564,387.644,391.049,393.322,397.312,399.524,402.322,403.964,407.729,412.004,413.309,414.952,419.737,423.817,427.799,431.047,434.684,438.704,440.909,444.516,447.921,451.941,453.831,456.853,460.258,466.401,468.043,470.631,474.111,475.753,477.741,481.401,485.061,488.721,492.381,494.368,496.011,499.536,503.488,507.126,510.553,512.871,514.438,517.777,521.414,525.434,529.072,531.869,534.667" svgx:width="0.54,0.45,0.29,0.53,0.54,0.53,0.53,0.21,0.21,0.54,0.21,0.37,0.22,0.5,0.17,0.22,0.21,0.54,0.45,0.49,0.37,0.31,0.21,0.54,0.45,0.31,0.53,0.29,0.37,0.22,0.5,0.57,0.17,0.22,0.64,0.54,0.53,0.44,0.49,0.54,0.3,0.51,0.45,0.54,0.3,0.47,0.45,0.82,0.22,0.34,0.46,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.47,0.54,0.49,0.45,0.31,0.21,0.45,0.49,0.54,0.49,0.37,0.37,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Zarogoulidis P, Investigators PC, Nguyen-Van-Tam JS (2014) Effectiveness </text>
   <text y="537.522" x="319.724,323.714,325.679,327.322,331.342,334.979,338.962,341.174,344.579,350.722,352.289,356.309,357.877,361.957,365.362,368.159,371.797,373.439,375.007,379.027,383.047,384.614,388.754,390.322,392.594,396.584,398.797,401.594,403.237,404.804,408.824,410.467,412.597,416.234,420.314,424.297,427.642,429.209,433.229,437.309,438.952,445.094,449.084,451.492,453.809,457.214,458.804,460.372,462.772,466.072,467.714,469.282,473.302,474.944,479.084,482.489,484.807,486.374,490.012,494.032,496.349,499.147,500.789,504.194,508.274,514.417,515.984,518.302,520.574,524.212,528.292,529.934,532.207,536.197" svgx:width="0.53,0.26,0.22,0.54,0.49,0.53,0.29,0.45,0.82,0.21,0.54,0.21,0.54,0.45,0.37,0.49,0.22,0.21,0.54,0.54,0.21,0.55,0.21,0.31,0.53,0.29,0.37,0.22,0.21,0.54,0.22,0.29,0.49,0.54,0.53,0.45,0.21,0.54,0.54,0.22,0.82,0.53,0.29,0.31,0.45,0.21,0.21,0.31,0.44,0.22,0.21,0.54,0.22,0.55,0.45,0.31,0.21,0.49,0.54,0.31,0.37,0.22,0.45,0.54,0.82,0.21,0.31,0.31,0.49,0.54,0.22,0.31,0.53,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">of neuraminidase inhibitors in reducing mortality in patients admitted to </text>
   <text y="546.522" x="319.724,323.744,327.734,330.532,334.672,336.239,338.557,341.962,343.552,345.194,350.609,352.177,354.494,358.514,360.157,361.724,365.744,369.374,373.357,376.994,381.014,384.037,387.442,389.084,393.472,395.114,399.839,403.499,408.284,411.944,416.084,420.164,426.307,429.967,433.627,435.269,438.659,440.227,442.439,446.422,449.219,450.862,452.429,456.449,458.302,461.939,465.366,467.684,469.251,473.241,477.261,478.566,480.209,483.614,485.256,491.399,495.036,497.354,500.759,502.994,506.399,510.419,513.824,515.414,518.714,521.511,523.079,525.876,527.519,531.509,533.474" svgx:width="0.54,0.53,0.37,0.55,0.21,0.31,0.45,0.21,0.22,0.72,0.21,0.31,0.54,0.22,0.21,0.54,0.48,0.53,0.49,0.54,0.4,0.45,0.22,0.58,0.22,0.63,0.49,0.64,0.49,0.55,0.54,0.82,0.49,0.49,0.22,0.45,0.21,0.29,0.53,0.37,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.21,0.53,0.54,0.17,0.22,0.45,0.22,0.82,0.49,0.31,0.45,0.3,0.45,0.54,0.45,0.21,0.44,0.37,0.21,0.37,0.22,0.53,0.26,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of </text>
   <text y="555.522" x="319.724,321.292,325.312,329.392,330.959,334.349,335.917,339.997,343.979,347.384,348.974,350.617,354.757,358.162,360.569,362.887,364.454,367.799,369.367,373.507,376.912,380.932,383.249,384.892,388.972,392.377,394.694,398.099,399.404,401.047,404.407,407.812,411.832,415.177,418.814,421.132,422.774,426.599,430.236,433.034,437.174,438.741,440.954,442.596,448.491,452.129,456.209,457.851,461.511,462.816,466.476,470.136,473.796,477.546,481.206,484.866" svgx:width="0.21,0.54,0.54,0.21,0.45,0.21,0.54,0.53,0.45,0.21,0.22,0.55,0.45,0.29,0.31,0.21,0.45,0.21,0.55,0.45,0.54,0.31,0.22,0.54,0.45,0.31,0.45,0.17,0.22,0.45,0.45,0.54,0.45,0.49,0.31,0.22,0.5,0.49,0.37,0.55,0.21,0.29,0.22,0.78,0.49,0.54,0.22,0.49,0.17,0.49,0.49,0.49,0.5,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">individual participant data. Lancet Respir Med 2:395–404</text>
   <text y="564.522" x="304.724,305.722,309.382,310.687,312.337,319.724,324.037,328.117,329.684,332.482,335.887,338.684,344.827,346.394,348.667,352.657,354.037,359.842,361.147,362.789,367.064,371.084,374.489,378.509,380.152,383.917,387.817,389.122,390.764,393.997,397.634,401.272,402.914,407.699,409.004,410.647,415.679,419.699,423.337,425.549,427.192,431.579,434.286,435.591,437.233,441.973,445.378,448.176,449.743,455.886,459.838,463.228,464.608,468.081,469.386,471.028,475.333,479.413,483.433,486.793,490.041,493.708,497.098,498.74,501.448,502.753,504.395,508.438,511.843,517.985,521.39,525.41" svgx:width="0.22,0.49,0.17,0.22,0.55,0.58,0.54,0.21,0.37,0.45,0.37,0.82,0.21,0.31,0.53,0.22,0.82,0.17,0.22,0.57,0.54,0.45,0.54,0.22,0.5,0.5,0.17,0.22,0.45,0.49,0.49,0.22,0.64,0.17,0.22,0.67,0.54,0.49,0.29,0.22,0.58,0.46,0.17,0.22,0.62,0.45,0.37,0.21,0.82,0.53,0.45,0.22,0.51,0.17,0.22,0.58,0.54,0.54,0.45,0.44,0.49,0.45,0.22,0.46,0.17,0.22,0.54,0.45,0.82,0.45,0.54,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 8. Adisasmito W, Chan PK, Lee N, Oner AF, Gasimov V, Aghayev F, Zaman </text>
   <text y="573.522" x="319.724,325.559,326.864,328.507,332.294,335.699,341.842,345.922,350.062,354.014,357.262,360.899,362.542,366.037,367.342,368.984,373.882,377.872,381.952,385.357,389.377,391.019,395.804,397.109,398.752,402.982,406.972,410.227,413.864,416.077,417.719,421.507,422.812,424.454,427.934,430.252,433.657,435.944,439.222,442.522,445.694,447.337,451.236,452.541,454.183,459.036,461.166,464.833,468.081,471.718,473.931,475.573,480.358,484.746,486.051,487.379,490.372,494.362,498.315,501.652,505.32,508.62,510.262,513.742,515.385,517.372,521.032,524.692,528.352,532.012,534.0" svgx:width="0.78,0.17,0.22,0.5,0.45,0.82,0.54,0.55,0.53,0.44,0.49,0.22,0.47,0.17,0.22,0.65,0.53,0.54,0.45,0.54,0.22,0.64,0.17,0.22,0.57,0.53,0.42,0.49,0.29,0.22,0.5,0.17,0.22,0.46,0.31,0.45,0.29,0.4,0.44,0.42,0.22,0.5,0.17,0.22,0.65,0.29,0.49,0.44,0.49,0.29,0.22,0.64,0.58,0.17,0.22,0.47,0.53,0.53,0.45,0.49,0.44,0.22,0.46,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">M, Bamgboye E, Dogan N, Coker R, Starzyk K, Dreyer NA, Toovey S (2010) </text>
   <text y="582.522" x="319.724,323.249,327.202,330.839,334.267,336.584,338.152,341.489,345.127,349.147,352.784,355.582,358.379,360.022,364.012,365.977,367.619,371.024,375.044,377.362,378.929,382.319,383.887,386.099,389.504,391.094,392.737,395.054,397.184,400.822,404.227,406.544,412.687,416.324,420.344,422.662,424.304,425.872,429.892,431.534,435.554,439.537,445.679,449.084,453.104,454.747,456.314,460.334,463.964,467.947,471.584,475.604,478.627,482.032,483.674,488.062,490.049,494.774,498.434,503.219,506.879,508.867,510.509,512.077,516.097,517.949,521.587,524.932" svgx:width="0.47,0.54,0.49,0.45,0.31,0.21,0.45,0.49,0.54,0.49,0.37,0.37,0.22,0.53,0.26,0.22,0.45,0.54,0.31,0.21,0.45,0.21,0.29,0.45,0.21,0.22,0.31,0.29,0.49,0.45,0.31,0.82,0.49,0.54,0.31,0.22,0.21,0.54,0.22,0.54,0.53,0.82,0.45,0.54,0.22,0.21,0.54,0.48,0.53,0.49,0.54,0.4,0.45,0.22,0.58,0.26,0.63,0.49,0.64,0.49,0.26,0.22,0.21,0.54,0.26,0.49,0.45,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Effectiveness of antiviral treatment in human influenza A(H5N1) infec-</text>
   <text y="591.522" x="319.724,322.042,323.609,327.599,331.619,334.417,335.722,337.364,340.769,344.789,348.194,349.784,353.084,355.882,357.449,360.247,361.889,365.879,367.844,369.487,372.892,374.534,379.214,380.804,384.794,388.934,392.339,393.929,395.572,399.112,402.517,404.834,406.402,410.039,414.059,416.377,418.019,421.844,425.481,429.501,431.069,433.866,436.184,438.621,441.665,442.97,444.613,447.2,448.843,450.538,454.558,456.41,460.048,463.475,465.793,467.435,472.288,473.855,476.653,478.295,481.955,485.615,489.275,490.58,494.24,497.9,501.56,505.22,508.97,512.63,516.29,519.95" svgx:width="0.31,0.21,0.53,0.54,0.37,0.17,0.22,0.45,0.54,0.45,0.21,0.44,0.37,0.21,0.37,0.22,0.53,0.26,0.22,0.45,0.22,0.62,0.21,0.53,0.55,0.45,0.21,0.22,0.5,0.45,0.31,0.21,0.49,0.54,0.31,0.22,0.5,0.49,0.54,0.21,0.37,0.31,0.29,0.44,0.17,0.22,0.34,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.22,0.65,0.21,0.37,0.22,0.49,0.49,0.49,0.17,0.49,0.49,0.49,0.49,0.5,0.49,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">tions: analysis of a Global Patient Registry. J Infect Dis 202:1154–1160</text>
   <text y="600.522" x="304.724,305.722,309.382,310.687,312.337,319.724,322.957,326.947,330.929,332.497,336.134,337.777,340.364,344.264,345.569,346.836,350.189,353.594,357.614,361.694,363.336,366.816,368.121,369.764,374.076,377.421,381.411,384.209,386.526,389.931,391.574,397.409,398.714,399.981,403.333,406.971,410.991,412.633,416.908,418.213,419.856,423.336,426.741,432.883,436.866,440.503,442.093,443.736,449.571,453.846,455.151,456.793,460.311,463.656,467.676,471.313,474.658,478.678,480.951,484.588,486.801,488.443,492.231,493.536,495.178,499.858,503.841,507.508,510.898,514.303,516.516,519.921,521.563,526.288,527.593" svgx:width="0.22,0.49,0.17,0.22,0.55,0.45,0.53,0.53,0.21,0.49,0.22,0.34,0.5,0.17,0.22,0.5,0.45,0.54,0.54,0.22,0.46,0.17,0.22,0.58,0.45,0.53,0.37,0.31,0.45,0.22,0.78,0.17,0.22,0.5,0.49,0.54,0.22,0.57,0.17,0.22,0.46,0.45,0.82,0.53,0.49,0.21,0.22,0.78,0.57,0.17,0.22,0.46,0.45,0.54,0.49,0.45,0.54,0.31,0.49,0.29,0.22,0.5,0.17,0.22,0.62,0.53,0.49,0.45,0.45,0.29,0.45,0.22,0.63,0.17,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 9. Louie JK, Yang S, Acosta M, Yen C, Samuel MC, Schechter R, Guevara H, </text>
   <text y="609.522" x="319.724,324.419,327.667,331.304,334.641,336.209,337.537,341.024,346.859,348.502,350.489,354.149,357.809,361.469,365.129,367.117,368.444,371.632,373.762,377.399,380.804,383.122,389.264,392.902,396.922,399.239,400.882,406.297,407.864,410.182,414.202,415.844,419.864,423.502,427.484,429.697,433.102,439.244,440.812,444.832,446.399,450.479,453.884,456.682,460.319,461.962,463.529,467.549,471.569,473.137,477.277,478.844,481.116,485.106,487.319,490.116,491.759,493.611,497.601,499.814,501.456,504.801,507.066,508.634,510.951,512.518,515.863,519.268,520.859,522.449,525.749,527.391,528.959,530.549,532.139" svgx:width="0.63,0.44,0.49,0.42,0.21,0.22,0.47,0.78,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.47,0.29,0.49,0.45,0.31,0.82,0.49,0.54,0.31,0.22,0.72,0.21,0.31,0.54,0.22,0.54,0.49,0.53,0.29,0.45,0.82,0.21,0.54,0.21,0.54,0.45,0.37,0.49,0.22,0.21,0.54,0.54,0.21,0.55,0.21,0.31,0.53,0.29,0.37,0.22,0.26,0.53,0.29,0.22,0.45,0.29,0.21,0.31,0.21,0.45,0.45,0.21,0.21,0.44,0.22,0.21,0.21,0.21,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">Uyeki TM (2012) Treatment with neuraminidase inhibitors for critically ill </text>
   <text y="618.522" x="319.724,323.864,327.269,329.587,331.154,334.792,338.812,341.129,343.927,345.569,350.984,352.552,354.869,358.889,360.532,362.099,366.119,369.749,373.732,377.369,381.389,384.412,387.817,389.459,393.847,395.489,397.477,402.202,405.862,410.647,414.307,416.294,420.434,424.514,430.657,434.317,437.977,439.282,440.924,445.199,446.789,448.357,452.377,454.019,455.714,459.734,461.586,465.224,468.651,470.969,472.611,477.464,479.031,481.829,483.471,487.131,490.791,492.096,495.756,499.416,503.076,506.736,510.486,514.146,517.806,521.466" svgx:width="0.55,0.45,0.31,0.21,0.49,0.54,0.31,0.37,0.22,0.72,0.21,0.31,0.54,0.22,0.21,0.54,0.48,0.53,0.49,0.54,0.4,0.45,0.22,0.58,0.22,0.26,0.63,0.49,0.64,0.49,0.26,0.55,0.54,0.82,0.49,0.49,0.17,0.22,0.57,0.21,0.21,0.54,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.22,0.65,0.21,0.37,0.22,0.49,0.49,0.17,0.49,0.49,0.49,0.49,0.5,0.49,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">patients with influenza A (H1N1)pdm09. Clin Infect Dis 55:1198–1204</text>
   <text y="627.522" x="304.724,305.722,309.382,313.042,314.347,315.99699999999996,319.724,324.419,327.667,331.304,334.641,336.209,337.537,341.024,346.859,348.164,349.807,353.594,357.232,359.497,363.517,366.314,368.587,372.224,373.792,377.812,379.454,384.179,388.904,390.209,391.852,395.639,397.852,401.257,405.337,406.927,410.594,413.894,415.536,418.124,421.604,422.909,424.551,428.046,432.066,436.146,437.736,441.719,445.738,449.818,451.461,454.048,458.436,459.741,461.383,464.623,466.191,467.781,471.418,472.746,476.233,482.068,483.373,485.016,488.256,490.693,493.993,495.636,499.978,505.813,507.118,508.761,513.441,515.653,519.013,522.351,525.988,530.008" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.63,0.44,0.49,0.42,0.21,0.22,0.47,0.78,0.17,0.22,0.5,0.49,0.29,0.54,0.37,0.31,0.49,0.21,0.54,0.22,0.63,0.63,0.17,0.22,0.5,0.29,0.45,0.54,0.21,0.49,0.44,0.22,0.34,0.46,0.17,0.22,0.47,0.54,0.54,0.21,0.53,0.54,0.54,0.22,0.34,0.58,0.17,0.22,0.46,0.21,0.21,0.49,0.22,0.47,0.78,0.17,0.22,0.46,0.29,0.44,0.22,0.58,0.78,0.17,0.22,0.62,0.29,0.45,0.45,0.49,0.54,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 10. Uyeki TM, Bernstein HH, Bradley JS, Englund JA, File TM, Fry AM, Graven-</text>
   <text y="636.522" x="319.724,322.522,324.794,328.432,329.999,334.019,335.662,339.142,340.447,342.089,346.814,350.174,353.422,357.502,361.139,365.159,366.802,370.267,374.947,376.252,377.894,382.619,386.024,388.289,392.429,396.067,398.279,399.922,403.402,407.789,409.094,410.737,415.574,417.141,419.354,422.151,426.171,430.161,434.181,435.824,438.411,444.246,445.551,447.193,448.776,451.573,455.563,459.583,461.226,467.061,471.741,473.046,474.688,477.306,481.296,485.316,489.336,492.133,494.406,498.396,502.416,504.058,507.846,511.206,512.511,514.153,518.001,522.021,523.588,527.668,531.688,534.006" svgx:width="0.37,0.31,0.49,0.21,0.54,0.22,0.46,0.17,0.22,0.63,0.45,0.44,0.54,0.49,0.54,0.22,0.46,0.62,0.17,0.22,0.63,0.45,0.29,0.55,0.49,0.29,0.22,0.46,0.58,0.17,0.22,0.63,0.21,0.29,0.37,0.54,0.53,0.54,0.22,0.34,0.78,0.17,0.22,0.21,0.37,0.53,0.54,0.22,0.78,0.62,0.17,0.22,0.34,0.53,0.54,0.54,0.37,0.31,0.53,0.54,0.22,0.5,0.45,0.17,0.22,0.5,0.54,0.21,0.54,0.54,0.31,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">stein S, Hayden FG, Harper SA, Hirshon JM, Ison MG, Johnston BL, Knight </text>
   <text y="645.522" x="319.724,323.204,326.564,327.869,329.512,335.407,338.752,343.469,347.107,350.744,352.957,354.599,358.987,360.292,361.934,365.804,367.372,368.962,372.629,375.929,377.571,380.931,384.426,385.731,387.111,393.066,397.056,398.646,400.499,404.136,405.779,410.054,413.841,415.146,416.789,421.176,422.766,426.404,429.621,433.026,437.046,441.126,444.764,446.976,448.618,452.384,455.879,457.184,458.826,462.366,465.726,469.116,470.684,474.089,475.731,479.571,483.059,484.701,486.688,490.348,494.008,497.668,501.328,503.316,504.958,509.233,510.823,512.391,516.411,517.978,521.323,524.728,526.318" svgx:width="0.46,0.45,0.17,0.22,0.78,0.45,0.62,0.49,0.49,0.29,0.22,0.58,0.17,0.22,0.5,0.21,0.21,0.49,0.44,0.22,0.45,0.47,0.17,0.22,0.82,0.53,0.21,0.26,0.49,0.22,0.57,0.5,0.17,0.22,0.58,0.21,0.49,0.43,0.45,0.54,0.54,0.49,0.29,0.22,0.5,0.47,0.17,0.22,0.5,0.45,0.45,0.21,0.45,0.22,0.58,0.47,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.57,0.21,0.21,0.54,0.21,0.45,0.45,0.21,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">SL, McGeer A, Riley LE, Wolfe CR, Alexander PE, Pavia AT (2019) Clinical </text>
   <text y="654.522" x="319.724,323.864,326.077,329.482,332.909,335.227,336.794,340.139,343.777,345.419,349.499,353.482,355.049,359.129,362.767,364.357,365.924,369.944,373.582,376.379,378.022,382.124,385.424,387.066,389.384,393.404,397.041,398.684,400.251,404.271,406.124,409.761,413.188,415.505,417.073,421.063,425.045,427.843,429.485,433.565,435.133,437.93,441.568,444.973,447.77,451.408,454.205,455.848,458.645,462.635,465.98,467.548,471.185,473.585,476.885,478.527,482.517,484.482,486.125,490.512,496.655,500.292,502.556,504.124,507.469,510.874,512.179,513.821,517.481,521.141,524.801,528.461" svgx:width="0.55,0.29,0.45,0.45,0.31,0.21,0.45,0.49,0.22,0.54,0.53,0.21,0.54,0.49,0.21,0.21,0.54,0.49,0.37,0.22,0.55,0.44,0.22,0.31,0.54,0.49,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.21,0.53,0.53,0.37,0.22,0.54,0.21,0.37,0.49,0.45,0.37,0.49,0.37,0.22,0.37,0.53,0.45,0.21,0.49,0.31,0.44,0.22,0.53,0.26,0.22,0.58,0.82,0.49,0.29,0.21,0.45,0.45,0.17,0.22,0.49,0.49,0.49,0.49,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">practice guidelines by the infectious diseases society of America: 2018 </text>
   <text y="663.522" x="319.724,323.707,327.847,331.927,335.332,337.604,341.242,342.884,346.874,350.894,352.537,356.617,358.184,361.589,365.609,369.629,373.619,376.417,377.984,380.699,382.004,383.647,385.964,388.094,391.732,395.137,397.454,403.597,407.234,411.254,413.572,414.877,416.519,419.864,423.884,427.522,433.664,437.654,441.794,443.924,447.914,452.054,455.999,459.299,460.889,464.294,467.512,469.079,471.794,473.099,474.742,478.147,482.167,486.247,487.889,489.457,493.477,496.274,498.592,500.159,502.477,506.459,508.777,510.344,514.334,518.354,521.759,523.349" svgx:width="0.53,0.55,0.54,0.45,0.31,0.49,0.22,0.53,0.54,0.22,0.54,0.21,0.45,0.54,0.54,0.53,0.37,0.21,0.37,0.17,0.22,0.31,0.29,0.49,0.45,0.31,0.82,0.49,0.54,0.31,0.17,0.22,0.45,0.54,0.49,0.82,0.53,0.55,0.29,0.53,0.55,0.54,0.44,0.21,0.45,0.43,0.21,0.37,0.17,0.22,0.45,0.54,0.54,0.22,0.21,0.54,0.37,0.31,0.21,0.31,0.53,0.31,0.21,0.53,0.54,0.45,0.21,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">update on diagnosis, treatment, chemoprophylaxis, and institutional </text>
   <text y="672.522" x="319.724,323.714,327.697,330.014,334.154,336.284,339.922,343.327,346.499,348.142,354.284,357.689,361.709,365.114,369.194,372.832,378.974,382.612,386.632,388.949,390.592,394.582,396.547,398.189,400.987,404.624,408.029,410.827,414.817,418.837,422.242,423.832,425.474,427.042,431.062,434.692,438.674,442.312,446.332,449.354,452.759,456.164,457.469,459.112,463.387,464.977,466.544,470.564,472.207,473.902,477.922,479.774,483.412,486.839,489.157,490.799,495.652,497.219,500.017,501.659,505.319,508.979,510.284,513.944,517.604,521.264,525.014,528.674,532.334" svgx:width="0.53,0.53,0.31,0.55,0.29,0.49,0.45,0.42,0.22,0.82,0.45,0.54,0.45,0.54,0.49,0.82,0.49,0.54,0.31,0.22,0.53,0.26,0.22,0.37,0.49,0.45,0.37,0.53,0.54,0.45,0.21,0.22,0.21,0.54,0.48,0.53,0.49,0.54,0.4,0.45,0.45,0.17,0.22,0.57,0.21,0.21,0.54,0.22,0.21,0.54,0.26,0.49,0.45,0.31,0.22,0.65,0.21,0.37,0.22,0.49,0.49,0.17,0.49,0.49,0.49,0.5,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">outbreak management of seasonal influenzaa. Clin Infect Dis 68:895–902</text>
   <text y="681.522" x="304.724,305.722,309.382,313.042,314.347,315.99699999999996,319.724,325.679,329.317,330.907,334.252,338.272,339.914,343.394,347.669,348.974,350.617,353.977,357.382,363.524,365.167,368.647,374.452,375.757,377.399,382.184,385.822,389.804,393.824,397.462,399.674,401.317,404.812,409.199,410.504,412.147,415.934,419.339,423.322,426.959,429.172,430.814,434.294,438.082,439.387,441.029,444.817,448.222,451.019,453.817,455.459,458.939,463.724,465.367,467.354,471.014,474.674,478.334,481.994,483.982,485.624,490.461,492.029,496.109,500.129,502.513,506.593,510.583,513.381,517.018,518.661,521.999,525.636,527.849,530.646,534.629,537.426" svgx:width="0.22,0.49,0.49,0.17,0.22,0.55,0.82,0.49,0.21,0.45,0.54,0.22,0.46,0.57,0.17,0.22,0.45,0.45,0.82,0.22,0.46,0.82,0.17,0.22,0.64,0.49,0.53,0.54,0.49,0.29,0.22,0.47,0.58,0.17,0.22,0.5,0.45,0.53,0.49,0.29,0.22,0.46,0.5,0.17,0.22,0.5,0.45,0.37,0.37,0.22,0.46,0.64,0.22,0.26,0.49,0.49,0.49,0.49,0.26,0.22,0.63,0.21,0.54,0.54,0.3,0.54,0.53,0.37,0.49,0.22,0.45,0.49,0.29,0.37,0.53,0.37,0.22" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;"> 11. Welch SC, Lam SW, Neuner EA, Bauer SR, Bass SN (2015) High-dose versus </text>
   <text y="690.522" x="319.724,322.522,324.839,328.244,332.264,336.344,339.749,341.88,345.96,347.595,351.675,355.665,358.463,362.1,363.735,367.725,370.523,374.16,375.75,378.068,381.473,387.615,389.183,392.573,394.14,396.353,397.988,399.84,403.83,406.043,407.678,409.995,412.125,415.763,419.168,421.485,427.628,431.265,435.285,437.603,439.238,443.228,445.193,446.828,449.625,453.293,456.63,460.268,462.398,466.035,467.67,469.238,473.258,476.888,480.87,484.508,488.528,491.55,494.955,496.59,498.158,502.178,503.813,507.218,511.298,515.28,516.87,519.188,520.823,522.39,526.41,528.683,532.32,536.34" svgx:width="0.37,0.31,0.45,0.54,0.54,0.45,0.29,0.54,0.22,0.54,0.53,0.37,0.49,0.22,0.53,0.37,0.49,0.21,0.31,0.45,0.82,0.21,0.45,0.21,0.29,0.22,0.26,0.53,0.29,0.22,0.31,0.29,0.49,0.45,0.31,0.82,0.49,0.54,0.31,0.22,0.53,0.26,0.22,0.37,0.49,0.45,0.49,0.29,0.49,0.22,0.21,0.54,0.48,0.53,0.49,0.54,0.4,0.45,0.22,0.21,0.54,0.22,0.45,0.54,0.53,0.21,0.31,0.22,0.21,0.54,0.31,0.49,0.54,0.3" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">standard dose oseltamivir for treatment of severe influenza in adult inten-</text>
   <text y="699.522" x="319.724,322.522,324.089,327.427,331.064,332.707,336.052,339.457,341.587,345.224,346.867,350.849,354.869,356.437,358.754,360.397,364.537,367.942,370.259,371.827,375.464,379.484,381.802,384.517,385.822,387.464,389.159,393.179,395.452,399.089,403.109,405.907,407.474,410.812,414.449,416.092,420.337,423.742,425.872,429.509,431.152,437.047,440.684,444.764,446.407,450.067,453.727,455.032,458.692,462.352,466.012,469.672,473.422,477.082,480.742,484.402" svgx:width="0.37,0.21,0.45,0.49,0.22,0.45,0.45,0.29,0.49,0.22,0.53,0.54,0.21,0.31,0.22,0.55,0.45,0.31,0.21,0.49,0.54,0.31,0.37,0.17,0.22,0.21,0.54,0.31,0.49,0.54,0.37,0.21,0.45,0.49,0.22,0.57,0.45,0.29,0.49,0.22,0.78,0.49,0.54,0.22,0.49,0.49,0.17,0.49,0.49,0.49,0.49,0.5,0.49,0.49,0.49,0.49" style="fill:rgb(0,0,0);font-family:MyriadPro-Light;font-size:7.5px;stroke:none;">sive care unit patients. Intensive Care Med 41:1365–1366</text>
  </g>
 </g>
</svg>
